Language selection

Search

Patent 1273883 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1273883
(21) Application Number: 1273883
(54) English Title: RECOMBINANT DNA MATERIAL COMPRISING BOVINE GROWTH HORMONE NUCLEOTIDE SEQUENCE
(54) French Title: DNA RECOMBINANT COMPORTANT UNE SEQUENCE NUCLEOTIDIQUE DE LA SOMATOTROPHINE BOVINE
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 15/18 (2006.01)
  • C07K 14/56 (2006.01)
  • C07K 14/61 (2006.01)
  • C12N 1/18 (2006.01)
  • C12N 9/64 (2006.01)
  • C12N 15/66 (2006.01)
  • C12N 15/81 (2006.01)
  • C12P 21/02 (2006.01)
(72) Inventors :
  • BOTSTEIN, DAVID (United States of America)
  • DAVIS, RONALD W. (United States of America)
  • FINK, GERALD R.ALISON (United States of America)
  • TAUNTON-RIGBY, ALISON (United States of America)
  • KNOWLTON, ROBERT G. (United States of America)
  • MAO, JEN-I (United States of America)
  • MOIR, DONALD T. (United States of America)
  • GOFF, CHRISTOPHER G. (United States of America)
(73) Owners :
  • COLLABORATIVE RESEARCH INC.
  • COLLABORATIVE RESEARCH INC.
(71) Applicants :
  • COLLABORATIVE RESEARCH INC.
  • COLLABORATIVE RESEARCH INC. (United States of America)
(74) Agent: SWABEY OGILVY RENAULT
(74) Associate agent:
(45) Issued: 1990-09-11
(22) Filed Date: 1984-02-27
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
470,911 (United States of America) 1983-02-28

Abstracts

English Abstract


ABSTRACT
A polypeptide product is produced by ex-
pression in yeast of a recombinant DNA material
comprising a bovine growth hormone nucleotide
sequence.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as
follows:
1. The recombinant DNA material comprising the
following bovine growth hormone nucleotide sequence:
89

<IMG>

2. The polypeptide product produced by
expression in yeast of the nucleotide sequence of
claim 1.
91

Description

Note: Descriptions are shown in the official language in which they were submitted.


1~738~
The present application is a division of
Canadian application No. 448,315 filed February 27,
1984 and relating to the use of the GALl yeast pro-
moter.
- Developments in recombinant DNA technology
have enabled the cloning in bacteria of the natural
coding sequence of a variety of genes. [See Seeburg,
P.H., Shine, J., Martial, J.A., Baxter, J.D. and
Goodman, H.M., Nature 270, 486-494 (1977) and Shine,
J., Seeburg, P.H., Martial, J.A., Baxter, J.D. and
Goodman, H.M., Nature 270, 494-499 (1977); Keshet, E.,
Rosner, A., Bernstein, Y., Gorecki, M. and Aviv, H.,
Nucleic Acids Res. 9, 19 (1981)i Miller, W. L.,
Martial, J. A. and Baxter, J.D., J. biol. Chem. 255,
7521-7524 (1980)]. Recently, recombinant DNA
techniques have been described in which a foreign
protein is cloned and expressed in yeast. Evidence for
foreign gene expression in yeast came from studies on
the _ vivo transcription of a rabbit globin gene
introduced into Saccharomyces cerevisiae on a yeast
plasmid vector. [See Beggs, 3.D., van den Berg, J.,
van Obyen, A., and Weissmann, C., Nature 283, 835-840
(1980)].
In an attempt to maximize expression of
foreign genes in yeast, their 5'-promoter region,
translation start and signal peptide sequences were
replaced with similar regions from the yeast genome.
,
. .

lX73~3
With bovine growth hormone, these regions were re-
placed with those from the yeast alcohol dehydrogenase
(ADHl) gene. Full length, biologically active bovine
growth hormone molecules were produced in yeast. [See
Hitzeman, R. A., Hagie, F.E., Levine, H.L., Goeddel,
D. V., Ammerer, G., and Hall, B.D., Nature 295,
717-722 (1981)]. Other promoters were employed but
demonstrated much less gene expression. The ability of
having a single strong promoter is highly useful to
permit the attainment of substantial levels of ex-
pression for a variety of genes in yeast.
In accordance with the invention of the
parent application, it has been discovered that
promoters for the GALl galactokinase gene are such a
; promoters. ln addition, these promoters are under
glucose repression. Thus, it becomes practical to
clone any one of a variety of genes including bovine
growth hormone, interferon, pre-prorennin and proren-
nin in yeast with expression maximized by direction of
a yeast GALl promoter.
According to the invention of the parent
application, the expression of a gene for a desired
polypeptide product is controlled by a GALl promoter
of a yeast strain such as Saccharomyces cerevisiae.
The GALl promoter is a DNA segment that contains the
.
~ -2-
- ',
- . .
:' ' - ~ ',
~ . . .

i~73~3
transcription start signal for galactokinase in yeast.
The sequencing information for the GALl promoter is
shown in Table 1.
-
:' . ' ' ' '
,
.

1;~'7~
T~LE I .
LISTING O~ THE SEQUENCE GAL125 AND GAL126
GAATTcGAcAGGTTATcAGcAAcAcAGTcATATccATTcTcAATTAGcTc
100
TACCACAGTGTGTGAACCAATGTATCCAGCACCACCTGTAACCAAAACAA
110 120 130 140 150
TTTTAGAAGTACTTTCACTTTGTAACTGAGCTGTCATTTATATTGAATTT
160 170 180 190 200
TCAAAAATTCTTACTTTTTTTTTGGATGGACGCAAAGAAGTTTAATAATC
210 220 230 240 250
ATATTACATGGCATTACCACCATATACATATCCATATACATATCCATATC
260 270 280 290 300
TAATCTACTATATGTTGTGGTATGTAAAGAGCCCCATTATCTTAGCCTAA
310 320 330 3~0 350
AAAAACCTTCTCTTTGGAACTTTCAGTAATACGCTTAACTGCTCATTGCT
360 370 380 390 400
ATATTGAAGTACGGATTAGAAGCCGCCGAGCGGGTGACAGCCCTCCGAAG
410 420 430 440 450
GAAGACTCTCCTCCGTGCGTCCTCGTCTTCACCGGTCGCGTTCCTGAAAC
460 470 480 490 500
GCAGATGTGCCTCGCGCCGCACTGCTCCGAACAATAAAGATTCTACAATA
510 520 530 540 590
CTAGCTTTTATGGTTATGAAGAGGAAAAATTGGCAGTAACCTGGCCCCAC
560 570 580 . 590 600
AAACCTTCAAATGAACGAATCAAATTAACAAÇCATAGGATGATAATGCGA
610 620 630 640 650
TTAGTTTTTTAGCCTTATTTCTGGGGTAATTAATCAGCGAAGCGATGATT
660 670 680 690 700
TTTGATCTATTAACAGATATATAAATGCAAAAACTGCATAACCACTTTAA
~4--

1;~7;~
TABLE I (contlnued)-
750
710 720 730 740 CTCTACCGG
CTAATACTTTCAACATTTTCGGTTTGTATTACTTCTTATTC [
MATGTMT
750
ATCC [GAL126]
AAAAGTATcAAcAAAAAATTGTTAATATAccTcTATAcTTTAAcGTcAAG
760 770 780 790 800
GAGAAAAAACCCCGGATCC [GAL125]
810 820
-4a-
.,

~;~738OE~
A DNA segment is provided which contains a
GALl promoter linked to a gene foreign to the yeast
genome for directing the expression of the gene within
a yeast cell. The segment is preferably a 0.755 or
0.82 kilobase DNA sequence from the yeast genome that
contains signals for transcription of the GALl gene
into mRNA and subsequent translation of the mRNA. The
coding sequence for galactokinase is not present in
this DNA fragment.
In a method for obtaining expression of a
desired polypeptide product in yeast, a yeast GALl
promoter is inserted in vitro in front of the gene for
that polypeptide product which is contained in a
chromosome or plasmid. These vectors are used to
transform cells and this new genetic information is
maintained in the cell and passed on to its progeny.
Synthesis of a polypeptide product using a
GALl promoter is advantageous for several reasons:
-GALl promoters are strong, leading to
synthesis of significant amounts of polypeptide
product,
-the GALl promoter activity can be regulated
by changing the yeast's carbon source permitting
propagation Gf the yeast without the potentially
deleterious effects of polypeptide production, since
overly high levels of the product may be toxic to
cells,

~t7;~8~3
-construction of a yeast strain with these
properties is particularly desirable for commercial
production of polypeptide products because of existing
large-scale yeast fermentation technology and also
because of the low toxicity of S. cerevisiae.
The invention of the present divisional
application relates to a recombinant DNA material
comprising the following bovine growth hormone nu-
cleotide sequence:

1~73~83
oVlC~o o_l--o oa~o o- ~--o oct~o ov~o
c ~ E
~ ~ a~ ~ _ ~: a~ t ~ ~ ~ ~ t
C t ~ L, ~ C~ ~
~ ~ v~ t
_ ~ o ~ ~ ~ o
~ ~ _ ~ ~ v~ cr ~ ~ ~ ~ a~ ~ z
o ~t~ ~ C t~ L ~ L ~ ~ c,~ ~ t~
o ~ ~o~ ~ ~ o ~o~ ~ o ~ o ~o ~-- o ~ ~
cn~ ~ a ~ e ~ c
~L ~ o c~ ~ ~ L ~ ~ ~ c ~ ~ ~ e
_ ~ ~ ~ ~ L ~ _ e ~ u ~ ~ ~ ~
~ e E~ ~ ~ ~S a~ _~ ~ ~
I~ ~ ~ ~ L ~ ~ ~ ~ ¢
~t
o ~ ~ e~
c~ Q~ n ~-- ~ ~ ~1-- a ~ ~ C~ ~ ~ ~
~,~ ~ ~ ` ~ ~ O ~ ~ ~ ~ c~ L 1-- v~ ~ _
e~ c~ q v.~ Q~ ~ e u~ _
~ ,~ ~ o ~o ~ ~ o ~ ~ tl~ o QI ~ o ~ o v ~ ~
~ S~- ~ ~ ~ ~ e
.!~ ~ ~ ~ ~ Q~ ~ V~ E ~: E S
--~ L l~ ~ c ~ _ t_~
~ ~ ~ e ~e c ~ ~0 t ~ ~ c e~
e~ , cn~ a~ ~ _~ v.~ ~e a~s
c ~ L ~ ~ ~ ~e ~ ~
~ ~ ~ L t-- L ~ C~ -- L
o ~ ~ ~ ~ ~ ~ c c~
L t~ 0 ~--~ 1-- --~ :~et: ~,~ .
~ ~ cn~ _ e ~
~ ~ e
_ ~ V ~ U ~ --~1: _ ~ ~ ~ Vl
v~ ~7~-- ~ ~ ~C!~ Ll-- L~ ~--
u~ c ~s e ~_ 0 ~ ~ ' e ~
O ~ ~ O ~ t~ ~ ~ ~ ~ ~I L t~
-
'' ' : : ' ~: '
-- , , --

3883
The present divisional application is also
directed to the polypeptide product produced by
expression in yeast of the nucleotide sequence defined
above.
Microorganisms prepared by the genetic
engineering processes described herein are exemplified
by cultures now on deposit with the American Type
Culture Collection, 12301 Parklawn Drive, Rockville,
Maryland. These cultures were deposited by Collabora-
tive Research, Inc. and are identified as follows:
Accession Number 20643, Strain DesignationCGY196, deposited September, 1982;
Accession Number 20661, Strain Designation
CGY457, deposited February, 1983;
Accession Number 20662, Strain Designation
CGY461, deposited February, 1983;
Accession Number 20663, Strain Designation
CGY528, deposited February, 1983.
As more fully described below, a particular
DNA segment is linked to a gene foreign to the yeast
genome and incorporated in a modified strain of
Saccharomyces cerevisiae so that it produces a poly-
peptide product under the control of a GALl promoter
of the yeast galactokinase gene. The S. cerevisiae is
genetically transformed with a novel recombinant DNA
plasmid. The plasmid was constructed by ligation of
DNA segments from the E. coli plasmid pBR322, yeast
,
:
. ~ ,
. . ~ .

t;~
genomic and plasmid DNA's, and synthetic DNA linkers.
The construction of plasmid pBR322, sequenced by J.G.
Sutcliffe, Cold Spring Harbor Symposium 43, 77-90
(1979), is shown diagrammatically in Table 2.
TABLE 2
_ HindIII
E~Rl \ ~
Bcl
pBR322
~ Aval
Ball
P~~I

1~'7;~
TABLE 3
Clal HindIII
E~RI \,~
~ Ba~T~I
Ylp5C~aIII
AvaI
~/Ura3
/\ BalI
P~l
--10--
:

1;~7;~383
Generally, in preparing the plasmid for joining with the
exogenous gene, a wide variety of techniques can be used,
including the formation of or introduction of cohesive
termini. slunt ends can be joined. Alternatively, the
plasmid and gene may be cleaved in such a manner that the two
chains are cleaved at different sites to leave extensions at
each end which serve as cohesive termini. Cohesive termini
may also be introduced by removing nucleic acids from the
opposite ends of the two chains or alternatively, introducing
nucleic acids at opposite ends of the two chains. Methods
which may be employed in joining cleaved DNA segments depend
on the nature of the termini, as described below.
~ Blunt-ended" refers to DNA molecules with duplex
base-paired termini. ~See Sgaramella, V., van de Sande, J.
H., and Khorana, H. G., Proc. Nat. Acaa. Sci. USA 67,
1468-1475 (1970).) The DNA blunt-end termini may be joined
by T4 DNA ligase with an apparent Rm of about 50~M DNA
5'-ends. (Sugino, A., Goodman, H. M., Heyneker, ~. L.,
Shine, I., Boyer, H. W., and Cozzarelli, N. R., J. Biol.
Chem. 252, 3987-3994 (1977).)
Blunt-ended DNA's are produced as for example, by
cleavage with any of a number of restriction endonucleases,
such as HaeIII. Alternatively, random shear breakage or a
restriction enzyme making staggered cuts, such as EcoRI,
HindIII, or BamHI, may be used, but the DNA termini must then
-11-
... . . .. . . . .
' - ' -
' .
' ' ' " ' ~ '

1.;~73~33
be made blunt by bioche~ical methods. Such biochemical
methods include incubation with single-strand-specific
nuclease Sl, as described in the following articles:
Ulbrich, A., Shine, J., Chirgwin, J., Pictet, R., Tischer,
E., Rutter, W. J., and Goodman, H. M., Science 196, 1313
~1977); Maniatis, T., ~ardison, R. C., Lacy, E., Lauer, G.,
O'Connell, C., Guon, D., Sim, G. X., and Efstratiadis, A.,
Cell 15, 687 (1978); Scheller, R. H., Thomas, T. L., Lee, A.
S., Klein, W. H., Niles, W. D., Britten, R. J., and Davidson,
H., Science 196, 197 (1977); and Charnay, P., Perricaudet,
M., Galibert, F., and Tiollais, P., Nucleic Acids Res. 5,
4479 (19781. Alternatively, blunt termini can be created by
incubation with T4 DNA polymerase [see Itakura, K., Hirose,
T., Crea, R., Riggs, A. D., Heyneker, H. L., Bolivar, F., and
Boyer, H. W., Science l9B, 1056 (1977); and Fraser, T. H.,
- and Bruce, B. J., Proc. Nat. Acad. Sci. USA 75, 5936 (1978)],
E. coli DNA polymerase lsee Seeburg, P. H., Shine, J.,
Martial, J. A., Baxter, J. D., and Goodman, H. M., Nature
270, 486 ~1977); Heffron, ~., So, M., and McCarthy, B. J.,
Proc. Nat. Acad. Sci USA 75, 6012 (1978); and Backman, K.,
Ptashne, M. and Gilbert, W., Proc. Nat. Acad. Sci. USA 73,
-
4174 (1976)~, and reverse transcriptase [see Ulbrich, A.,
Shine, J., Chirgwin, J., Pictet, R., Tischer, E., Rutter, W.
J., and Goodman, H. M., Science 196, 1313 (1977)] with added
deoxynucleotide triphosphates.
-12-
.~
, .
' ' ' ~ ' -
.
.' ~ ', '

83
~ Cohesive-ended~ refers to DNA molecules with
single-stranded termini. The ~ingle-stranded extensions are
complementary and antiparallel. (See Mertz, J. E., and
Davis, R. W., Proc. Nat. Acad. Sci. ~SA 69, 3370-3374 (1972).)
Joining of base-paired duplexes occurs when the
nucleoside at a 5'-end carries a phosphate group and the
co~plementary nucleoside opposite to it carries a free
3'-hydroxyl group. Two phosphodiester bonds would be made
essentially simultaneously and the joined duplexes would have
their nucleotide seguence inverted with respect to one
another.
There are three general approaches to creating
cohesive-ends on DNA:
1. digest DNA with type II restriction endonucleases
that introduce staggered scissions at unique
sequences;
2. treat linear DNA molecules with terminal
deoxynucleotidyl transferase to generate
single-stranded tails of either poly(dA) and
poly(dT) or poly(dC) and poly(dG) at the 3'-hydroxyl
terminus of different populations of DNA molecules;
and
3. add to blunt-ended molecules linkers, which are
- short duplexes containing a restricton endonuclease
cleavage site. Such linkers are joined to DNA by T4
DNA-ligase catalyzed blunt-end joining. After
-13-

~'7~ ~8~
digesting the product with the restriction enzyme
that cleaves the linker, the DNA is terminated with
cohesive ends.
These methods are well known, as exe~plified in the following
articles: Sadler, J. R., Betz, J~ L., Teiklenburg, M.,
Goeddel, D. V., Yansura, D. G., and Car~thers, M. H., Gene 3,
211 (1978); Bahl, C. P., Marians, K. J., Wu, R., Stawinsky,
J., and Narang, S. A., Gene 1, 81 (1976); and Scheller, R.
H., Dickerson, R. E., Boyer, H. W., Riggs, A. D., and
Itakura, K., Science 196, 177 (1977).
~ Linker" refers to a duplex, blunt-ended DNA molecule
from 6-14 base pairs in length, containing the recognition
site for a restriction endonuclease that produces cohesive
termini.
In the preferred embodiment of the present invention, the
plasmid serves as the vehicle for introduction of the foreign
gene into the yeast cell. However, it is not necessary to
ùse a plasmid, since any molecule capable of replication in
yeast can be employed. The DNA molecule can be attached to a
vector other than a plasmid, which can be a virus or cosmid
as known in the art; or it can be integrated into the
chromosome.
The recombinant plasmid or plasmid chimera is constructed
in vitro. Since the annealing and ligation process not only
results in the formation of the recombinant plasmid, but also
in the reclrcularization of the plasmid vehicle, a mixture of
-14-
.

1 ~ 7~
ligation products is obtained involving the original plasmid
and the foreign DNA. Only the original plasmid and the DNA
chimera consisting of the plasmid vehicle and linked foreign
DNA will normally be capable of replication. When the
mixture is employed for transformation of the bacteria,
replication of both the plasmid vehicle genotype and the
foreign genotype will-occur.
The transformation of the bacterial cells will result in
a mixture of bacterial cells, the dominant proportion of
which will not be transformed. Of the fraction of cells
which are transformed, some significant proportion, but in
some cases a minor proportion, will have been transformed by
recombinant plasmid. In any event, only a very small
fraction of the total number of cells which are present will
have the desired phenotypic characteristics.
In order to isolate only the bacteria containing the DNA
chimera or the original plasmid, a selectable genetic marker
is included on the original plasmid, such as resistance to an
antibiotic or heavy metal. The cells can then ~e grown on ~a
20 agar medium containing the growth inhibiting substance.
Since E. coli is used as the bacteria for transformation in
the present invention, ampicillin is used as the growth
inhibiting material to afford selection in E. coli. Only
available cells hav;ng the resistant genotype will survive.
If the foreign gene does not provide a phenotypical property,
which allows for distinction between the cells transformed by
-15-
' ~ .

the plasmid vehicle and the cells transformed by the plasmid
chimera, a further step is necessary to isolate the
replicated plasmid chimera from the replicated plasmid
vehicle. The steps include lysing of the cells and isolation
and separation of the DNA by conventional means or random
selection of transformed bacteria and characterization of DNA
from such transformants to determine which cells contain
molecular chimeras. This is accomplished by physically
characterizing the DNA by electrophoresis, gradient
centrifugation, sequence analysis or electron microscopy.
Cells from various clones may be harvested and the
plasmid D~A isolated from these transformants. The plasmid
DNA may then be analyzed in a ~ariety of ways. One way is to
treat the plasmid with an appropriate restriction enzyme and
analyze the resulting fra~ments for the presence of the
foreign gene. Other techniques have been indicated above.
Once the recombinant plasmid has been replicated in E.
coli and isolated, the E. coli may be grown and multiplied
and the recombinant plasmid employed for transformation of
the S. cerevisiae strain.
The term GALl promoter as employed in the present
invention, also designated PGALl, is preferrably either a
0.755 or 0.82 kilobase DNA sequence from the yeast genome
which contains signals for transcription of the GALl gene
into mRNA and subsequent translation of the mRNA. The coding
sequence for galactokinase is not present in this DNA
-` - - .. . .....
.
.

~2~3~83
fraqment, but ~he fragment can direct the expression of
foreign genes and the regulation follows the mode for the
GALl gene. (See St. John, T. P. and Davis, R. W., J. Mol.
Biol. 152, 285-315 (1981).]
The bovine growth hormone gene referred to, which can be
promoted by the promoter used in this invention, is a protein
of about 22,000 daltons synthesized in anterior pituitaries.
The hormone is required for pre-adult growth. Bovine growth
hormone (BGH) contains a single polypeptide of 191 amino
10 acids with two disulfide bridges synthesized initially as a
pre-growth hormone containing an amino-terminal extension of
26 amino acid residues. [See Miller, W. L., Martial, J. A.
and Baxter, J. D., J. Biol. Chem. 255, 7521-7524 (1980);
Xeshet, E., Rosner, A., Bernstein, Y., Gorecki, M. and Aviv,
~., Nucleic Acids Res. 9, 19-30 (1980); and Lingappa, V. R.,
- Deviller-Thiery, A. and Blobel, G., Proc. Nat. Acad. Sci. USA
74, 2432-2436 (1977).1
The interferon gene referred to, which can be promoted by
the promoter used in this invention, ls any one of the three
20 classes of interferon qenes described below:
(a) leukocyte - derived from leukocyte or lymphoblastoid
cells, designated LeIFN or IFN-~;
(b) fibroblast - derived from fibroblast cells,
designated FIFN or IFN-B; and
(c) lmmune - derived from mitogen- or antigen-stimulated
lymphoid cells, designated IFN-~.
-17-
r ~
'~
_. .. . ~. ...
~, .
' ~ ' '
: . .
.

~ 3~83
Such interferon genes are described in
-Goeddel, D. V., Leung, D. W., Drell, ~. J., Gross,
M., Lawn, R. M., McCandliss, R., Seeburg; P. H., Ullrich,
A., Yelverton, E., and Gray, P. W., Na ure 290, 20-26
(1981).
-Allen, G. and Fantes, K. H., Nature 287, 408-411
(1980) and preceding reference.
-Zoon, X. C., Science 207, 527-528 (1980~.
-Mantei, N., Schwartzstein, M., Streuli, M., Panam,
S., Nagata, S., and Weissman, C., Gene 10, 1-10 (1980).
-Streuli, M., Nagata, S., and Weissman, C., Science
209, 1343-1347 (19801-
Preferably in the methods of this invention pre-prvrennin
and prorennin can each be obtained by isolation of
pre-prorennin DNA material. The pre-prorennin is a precursor
of prorennin. By removing portions of the pre-prorennin DNA,
one could obtain genetic material which will code for
prorennin.
Pre-prorennin or prorennin genes in accordance with this
invention comprise any nucleotide sequences coding for the
amino acid sequence of pre-prorennin or prorennin
respectively and exclude any intervening nucleotide sequences
present in the genomic DNA encoding pre-prorennin or
prorennin respectively. These genes are also provided
attached to vectors which replicate in suitable host cells.
-18-
-
:' ' . ' ' . ' ' , ,

~7~8~3
For the purposes of this application, the prorennin gene
is defined as any sequence of nucleotides which codes for the
prorennin molecule, the amino acid sequence of which is
described in the literature (8. F~ltmann, V.B.Pedersen,
H.Jacobsen, D.Rauffman, and G.Wybrandt, Proc. Nat. Acad. Sci.
USA 74, 2321-2324 11977).
The pre-prorennin gene includes the sequence of
nucleotides coding for prorennin, but also includes 48
additional nucleotides on the ~' end which code for the
amino-terminal precursor polypeptide found on the
pre-prorennin enzyme.
The yeast strain employed as the host cell in the
preferred embodiment of the present invention is
Saccharomyces cerevisiae, a common laboratory strain of yeast
used for its low toxicity and well-known genetic
characteristics. This strain is readily cultivatable on a
large scale. However, the recombinant DNA material of the
present invention containing a GALl promoter can be used to
express a polypeptide product in any yeast cells capable of
transformation, including yeast mutants that alter regulation.
Saccharomyces cerevisiae is a yeast whose vegetative
reproduction occurs by multilateral budding cells. Such
cells are usually found in pairs or small clusters. The
species $s usually diploid where spores are produced directly
in vegetative cells, but the species can also be grown in
higher ploidy. In addition, S. cerevisiae forms an ascus
, ~ - 1 9 - .
.
`
`, ~ ,`, :
~''-
: . ' ~ , ' '

1 ~ 73 ~
with one to four spheroidal spores in each ascus. The ascusfor this 6pecies does not rupture at maturity. The yeast has
a strongly fermentative as well as respiratory metabolism.
Selected ~trains are referred to as distillers' yeasts and
baker'~ yeast.
The vast majority of yeasts can be cultivated under
relatively uniform conditions on common laboratory media.
The usual growth requirements of yeast include:
ta) organic carbon compound for carbon and energy;
(b) organic or inorganic nitrogen for the synthesis of
proteins and nucleic acids;
(c) various minerals (including compounds furnishing
trace elements); and
(d) frequently a mixture of vitamins.
Such growth requirements are met by yeast nitrogen base (YNB,
obtained from Difco), a chemically defined medium which
contains a number of trace elements, 9 vitamins, trace
amounts of amino acids to stimulate growth of certain
fastidious yeasts and the principal minerals, potassium
phosphate, magnesium sulfate, sodium chloride, and calcium
chloride. The nitrogen source is ammonium sulfate. The
desired carbon source must be added and is normally at a
concentration of 0.5 - 3~. Additions are made to this
medium to fit particular strain requirements. The pH range
of the medium is usually from pH 3 - 8. The preferred range
is pH 4.5 - 6.5.
-20-
-- .
.

~738~
The starting point for obtaining the cells o~ the present
invention is the use of recombinant DNA techniques known in
the art to obtain the genetic material desired and to insert
it into the host cell after which the host cell is cloned.
Preferably, the gene which one wishes to ultimately clone
in yeast is isolated in a first step by obtaining messenger
RNA of the gene from a primary source. In the case of BGH,
this is obtained by isolation from the bovine pituitaries.
The messenger RNA can be isolated as by the method of Deeley,
et al. (R.G. Deeley, J.I.Gordon, A.T.H. Burns, R.P. Mullinix,
M.Bina-Stein, R.E. Goldberger J.Biol.Chem. 252 8310-8319
tl977]) and poly A-enriched RNA can be obtained by
chromatography over oligo (dT) cellulose by the method of
R.C. Desrosiers, K.H. Friderici, ~ F.M. Rottman Biochemistry -
4 4367-4374 (19751.
The messenger RNA is then converted to double-stranded
DNA by conventional means. First, the complimentary copy of
the DNA is made from the messenger RNA by conventional
recombinant DNA means as by the use of AMV reverse
20 transcriptase. For example, the methods of A. Efstratiadis,
.C. Kafatos, A.M. Maxam and T. Maniatis, Cell 7 279-288
(1976), R.Higuchi, G.V. Paddock, R.Wall and W.Salser, Proc.
Nat. Acad_.Sci. USA 73, 3146-3150 (1976), D.L.Kacian and J.C.
Myers, Proc. Nat. Acad. Sci. VSA 73, 2191-2195 (1976), M.P.
Wickens, G.N. Buell and R.T. Schimke, J. Biol. Chem. 253,
2483-2495 (1978), G.M.Wahl, R.A. Padgett and G.R. Stack, J.
~ ., .... ,_ _. . . . . . .. .
~ ~'

1273883
Biol. Chem., 254, 8679-8689 (1979) can be used to obtain the
copy DNA (cDNA). The RNA portion can be disposed of by
breaking the ctrands as known in the art using any of the
above methods or by heat denaturing according to the method
of Wickens, et al. (1978).
Next, enzymes such as E. coli DNA polymerase I or AMV
reverse transcriptase can be used to turn the cDNA into
double-stranded DNA using the methods of the publications
above and J.I. Gordon, A.T.H. Burns, J.L. Christmann & R.G.
Deeley, J. Biol. Chem. 253, 8629-8639 (1978).
Thirdly, synthetic linkers can be attached to both ends
of the double-stranded DNA as for example by the use of
Hind~II or EcoRI synthetic oligonucleotide linkers using
conventional methods such as described in R.H. Scheller, T.L.
Thomas, A.S. Lee, W.H.Klein, W.D. Niles, R.J. ~ritten and
E.H. Davidson, Science 196, 197-200 (1977), T.H. Fraser and
B.J. Bruce, Proc. Natl. Acad. Sci. USA 75 5936-5940 (1978),
A. Ullrich, J. Shine, J. Chirgwin, R. Pictet, E. Tischer,
W.J. Rutter & H.M. Goodman, Science 196, 1313-1319 (1977), J.
Shine, P.H. Seeburg, J.A. Martial, J.D. Baxter & H. M.
Goodman, Nature 270, 494-499 (1977), or P.H. Seeburg, J.
Shine, J.A. Martial, J.D. Baxter & H.M. Goodman, Nature 270,
486-494 (1977).
;:~
~ -22-
"
~' '
.. .
. . .
: : ~ ', ' `' - . ~ `
'- . :,
: ~ ` ' . ' - ' : ' `

1~7~3
In a fourth step, thè DNA molecule is integrated into the
chromos~me or attached to a vector which can be a plas~id,
virus or cosmid as known in the art. Such vectors include:
pBR322 (F.Bolivar, R.L.Rodriguez, P.J. Greene, M.C.
Betlach, H.L. Heyneker, H.W. Boyer, ~.H. Crosa, S.
Falkow, 1977 Gene 2 95-119)
pMB9 (R.L. Rodriguez, F. Bolivara, H.M. Good~an,
H.W. Boyer, M.C. Betlach in ~Molecular Mechanisms in the
Control of Gene Expression~ lD.P. Nierlich, W.J. Rutter,
C.F. Fox, Eds.] 471 Academic Press New York 1976)
pSC101 (S.N. Cohen, A.C.Y. Chang, H.W. Boyer, R.B.
Helling 1973 Proc. Nat. Acad. Sci. USA 70 3240)
~ gtWES (D.Tiemeier, L. Enquist, P. Leder Nature 263
526-52~) (1976)
~charon phages (F.R. Blattner, et al Scienc~ 16
161-169) (1977)
fl R229 (J.D. Boeke Molec. Gen. Genetics 181,
288-291) (1981)
pJC75-58 (J. Collins Methods in EnzYmologY 68
309-326) (1979)
This step is again carried out outside of the final host
cell. Useful techniques for this procedure are described in
the references above in connection with the linkers as well
as in the following publications: V. Hershfield, H.W. Boyer,
C. Yanofsky, M.A. Lovett & P.R. Helinski, Proc. Natl. Acad.
Sci. USA 71, 3455-3459 (1974), N.E. Murray ~ R. Murray,
-23-
~, . . . . . . .. . . . .. . . . ..
: ' ' - ' . "
~ ~' ~' ' ` -'` '

3~8;3
Nature 251, 476-482 (1974), F.R. Blattner et al, Science 196,
161-169 (1977).
In a fifth step, the recombinant DNA molecule can be
introduced into the cytoplasm of the host cell line using
conventional procedures such as described in M. Mandel ~ A.
Higa (1970) J. Mol. Biol. 53 159-162, P.C. Wensink, D.J.
Finnegan, J.E. Donelson & D.S. Hogness, Cell 3, 315-325
(1974), S.N. Cohen, A.C.Y. Chang and L. Hsu, Proc. Natl.
Acad. Sci. USA 69, 2110-2114 (1972), B.M. Goodman, and R.J.
MacDonald, Methods_in EnzYmolo~ 68, 75-90 (1979), E.M.
Lederberg and S.N. Cohen, J. Bact. 119, 1072-1074 (1974).
Recognition of the correct clone may be accomplished by
the method of hybridization selection or by probing with
synthetic oligonucleotides, (T. Taniguchi, Y. Fu~ii, Ruriyama
and M. Muramatsu, Proc. Natl._ Acad._Sci. USA 77, 4003-4006
(1980), R.P. Ricciardi, J.S. Miller & B.E. Roberts, Proc.
Natl. Acad. Sci. USA 76, 4927-4931 (1979), D.L. Montsomery,
B.D. Hall, S. Gillam and M. Smith, Cell 14, 673-680 [1978]).
The newly modified host cell is then cloned and
expression of the material desired obtained. ~or example,
the technique of Guarente, et al. using the lactose operon
promoter, (1980) (L. Guarente, G. Lauer, T.M. Roberts & M.
Ptashne, Cell 20, 543-553 ~1980], L. Guarente, T.M. Roberts
M. Ptashne, Science 209, 1428-1430 [1980]) allows one to
obtain and optimize expression of foreign DNA.
In the present invention, the arrangement of the DNA
segments in the plasmid construction is shown diagramatically
in Table 4.
-24-
.

1,c:7~883
TAB LE 4
. . _
jl 2 5 )
Amp / C4)
~ \ X'
E. coli
origin
_ _
2~2) (3~ ~
origin \ ~ /URA3
... ,. . ~ . , , . .. . . _ . .... . . . .. .... . .
-
- . ,: ,
, - : - - ', - .
.
.

1;~73~8;~
This construction consists of several components
generally used ~n ~huttle~ vectors, i.e., plasmids that can
be maintained either in E. coli or yeast. The plasmid
described in Table 4 is a modified construction of plasmid
YIp5, as described`by K. Struhl, D. T. Stinchcomb, S. Scherer
and R. W. Davis, Proc. Nat. Acad. Sci. USA 76, 1035-1039
. . .
(1979) [see Table 3]. Segment ~1) is a 2.4 kilobase fragment
of plasmid pBR322 and contains a DNA replication origin and
B-lactamase gene, allowing propagation of the DNA in E. coli
and continuous selection for its presence by ampicillin
resistance. Segment (2) is a 1.6 kilobase HpaI to HindIII
fragment of the yeast 2~plasmid containing an initiation
site for replication in yeast. lThe 2~ plasmid is described
by J. L. Hartley and J. E. Donelson, Nature 286, 860-865
(1980)]. Segment (3) is the URA3 gene from the yeast genome
(1.1 kb long) to allow the selection of yeast harboring the
plasmid by virtue of its complementation of the ura3
mutation in the host strain. lThe URA3 gene is described by
M. Bach, F. Lacroute and D. Botstein, Proc. Nat. Acad. Sci.
20 USA 76,386-390 (1979).1
Segment (4) is a 0.755 or 0.82 kb fragment of DNA from
the yeast genome which contains signals for transcription of
the GALl gene into mRNA and subsequent translation of the
mRNA. The GALl gene is repressed when the yeast strain is
grown ~n high glucose medium. The coding sequence for
galactokinase is not present in the 0.755 or 0.82 kb
-26-
,
.
.,' ' ' .

~ ~73~383
fragments. These pieces of DNA can direct the expression of
foreign genes and the regulation follows the mode for the
GALl gene as herein disclosed.
Segment (5) is a fragment of DNA which encodes for the
desired polypeptide product sequence. This piece of DNA is
oriented so that transcription of the mRNA is controlled by a
GALl promoter. The sequence coding for the signal peptide
was removed and an ATG translational initiation codon was
incorporated. Therefore, a gene initiated by methionine is
used for the studies.
The plasmid was constructed by ligation of DNA pieces
from various sources and synthetic linkers. The sequence at
the junction of the 0.82 kb GALl promoter and the foreign
gene sequence is:
(I) PGALl - A6 C C C C G G A T C T C G A C C - A T G - X
where X is the foreign gene. The sequence TCGACC is part of
a synthetic SalI linker and CCCCGGATC is part of a BamHl
- 20 linker.
The sequence at the junction of the 0.755 kb GALl
promoter and the foreign gene sequence is:
PGA~ T T A T T C C T C T A C C G G A T C A A - A T G - X,
-27-
. .. . . . . .
!

t73~83
where X is the foreign gene.
The plasmid was first cloned and amplified in E. coli and
then transformed into yeast. Expression levels were
determined for various genes using similar constructi~ns. In
the case of BGH, for example, a fusion gene of BGH' 'lacZ
replaced the BGH gene (at X) in Figure 3. This construction
contains essentially the whole BGH sequence (only the coding
sequence for 4 amino acids for the N-terminus is missing) and
nearly the whole lacZ gene. By monitoring the
~-galactosidase (lacZ gene product) activity, approximately
80,000 molecules of fusion protein were produced per cell in
strain CGY 150 (~ leu2-3 ura3-52 GAL ).
Permissible modlfications in the production of a
polypeptide product in yeast would include:
--Different terminators can be used.
--With respect to BGH, the N-terminal amino acid is
heterologous for BGH with both phenylalanine (Phe) and
alanine ~Ala) being observed. This heterogeneity is a
consequence of ambiguous processing of the precursor
molecule (pre-growth hormone). The gene described above
codes for the Phe-BGH. The other gene for Ala-BGH can
also be ùsed for expression.
--Mutations in the GALl promoter (element (4) in Table
4) can affect the level of expression or the mode of
regulation. Other mutations in the chromosomal genome
may also have the same effects. In fact, there are
; -28-
,
'' . ' -, . , ~ ''~
.'' ' ' ' '

~ 8~3
mutants available to turn a GALl promoter on
constitutively. These strains can be used to get higher
levels of expression.
--The DNA segment containing PGALl linked to the
forei~n gene (elements t4) and ~) in Table 4) can be
integrated into the yeast chromosome for a stable
construction rather than having this segment on an
extrachromosomal plasmid.
--The ATG initiation codon in the foreign gene can be
replaced by other sequences such as sequences coding for
a signal peptide. Further, the protein could be secreted
from yeast cells into the medium.
--Different lengths and sequences of DNA can be used
at the junction of the GALl promoter and the foreign gene
sequence to optimize the level of production. For
instance, sequence (I) could be changed to:
(II) PGA~l - A6 C C C C G C A A G C T T A T C G - A T G - X
-
Other sequences in this region can be derived by
performing mutagenesis.
--Different lengths of the GALl promoter can be used.
--A terminator for transcription from the yeast genome
can be added to the C-terminus of the BG~ gene.
--The term GALl promoter, as used herein, includes any
portion of a 0.755 or 0.82 kilobase DNA sequence which
acts to cause expression of galactokinase in yeast.
-29-
.
.. ~ ` .
- . ~ . . .

~ ~ 7~ ~3
The yeast strain described herein will
produce the desired polypeptide product if the medium
contains galactose. The medium should contain 6.7 g/l
yeast nitrogen base, 2% galactose and the appropriate
amino acids. If the polypeptide product proves to be
; deleterious to the hoststrain, the production can be
repressed by growing the yeast in a medium containing
2% glucose, 6.7 g/l yeast nitrogen base and then
inducing the production of the polypeptide product
after growth has ceased by transferring the yeast to
the galactose me~ium. The cells are centrifuged and
the cell-free extract is obtained by breaking cells by
vigorous vortexing with glass beads.
The following non-limiting examples illus-
trate the inventions of both the parent and divisional
applications.
-30-
,
.
- - , . .
. ~. .- . , ~ .

~738~;~
EXAMPLE l
.
Production of Bovine Growth Hormone
1. Isolation of BGH mRNA
Bovine pituitaries were collected shortly after killing and
were frozen immediately on dry ice. 14.4 grams of tissue
were disrupted by means of a Waring blender into 200 ml of
cold buffer (10 C) consisting of 50 mM Tris-HCl, pH 7.5, 8 M
guanidine HCl, and 1 mM dithiothreitol. The resulting
solution was centrifuged at 5 C in a Sorval SA600 rotor at
10,000 rpm for 17 minutes. The material was resuspended by
homogenization and sat on ice for one hour in 40 ml of cold
buffer consisting of 20 mM NaOAc, 20 mM EDTA, and then
treated with half volume of ice-cold absolute ethanol. After
l hour at -20 C, the precipitate was pelleted by a
centrifugation at 3,000 rpm for 30 minutes at -10 C. The
pellet was resuspended two times in 20 ml of the preceding
buffer, treated with half volume of ice cold absolute
ethanol, incubated one hour at -20 C and the pellet
collected as decribed previously. The final pellet was
resuspended in 8 ml of 0.1 M EDTA with heating at 60 C, and
then 0.1 volume of 2M NaOAC, pH 5.0, and 2 volumes of
ice-cold absolute ethanol were added and the solution placed
at -20 overnight. The RNA precipitate was collected by
-31-
.

1~ 7 ~
centrifugation at 8,000 rpm for 20 minutes at -10 C, and was
dissolved in 5 ml water. The yield was 5 mg RNA. The RNA
solution was diluted with 5 ml of 2x concentrated binding
buffer (20 mM Tris-~Cl, pH 7.5; 2mM EDTA, pH 7.0; 0.4~ SDS;
and 0.24 M NaCl). The RNA was applied to a 1.5 ml oligo-dT-
cellulose column, the column was washed with lx concentrated
binding buffer and then the poly A-containinq RNA (mRNA) was
eluted by washing the column with binding buffer containing
no NaCl. About 100 mg of poly A-conta;ning RNA were
obtained. A portion of the poly A-containing RNA was
translated in vitro in a rabbit reticulocyte lysate system
[Pelham, H.R.B. and Jackson, R.J., Eur. J. Biochem. 67
247-256 ~1976)] to confirm the isolation of mRNA coding for
BGH.
2. Preparation of double-stranded copy DNA (cDNA)
About 2.5~ 9 of cDNA was synthesized from 25 ~ 9 of the poly
A-containing RNA by incubation for one hour at 42 C in 50 mM
~ris-HCl, pH 8.3; lO0 mM KCl; 8mM MgC12; 0.4 mM
dithiothreitol; 5 mM each dATP, dGTP and dTTP; and 20~ g/ml
oligo (-dT)12_18, containing lOO units reverse
transcriptase and 1.3~Ci d-32P-dCTP(1.8 Ci/mmole). After
heating the reaction mixture at 100 C for 3.5 minutes, quick
chilling on ice for approximately 3 minutes and removing the
precipitated protein by centrifugation, to the
-32-
.:. .
~,
.. , .. . . ... , . .. . . .. _ _ .
.
-
'
.
' ~

~ ~73883
supernatant was added HEPES-NaOH, pH 6.9, to 100 mM; MgC12
to 5 mM; dithiothreitol to 0.5 mM; and deoxynucleos~de
triphosphates to 0.125 mM. Incubation of this mixture with
300 units of E. coli DNA polymerase I for 2.5 hours at 15 C
produced 1.8,f~9 of double-stranded cDNA. The DNA was phenol
extracted, separated from unincorporated triphosphates by
chromatography on Sephadex G-100 113.5 ml column, 0.7 cm x 35
cm, eluted with 20 mM NaCl) and ethanol precipitated
overnight at -20 C by addition of 1/10 volume 2 M NaOAc, p~
5, and 2.5 volumes cold ethanol. The double-stranded cDNA
was then treated with 8,000 units of Sl nuclease at 37 C for
one hour in buffer (0.3 M NaCl, 30 mM NaOAc, pH 4.6, 3 mM
ZnSO4). The reaction was terminated by addition of EDTA to
10 mM, and Tris-HCl, pH 8.3, to 200 mM, and the mixture
applied to a Biogel A-150m column (0.75 cm x 40 cm)
equilibrated and eluted with 10 mM Tris-HCl, pH 7.5, 250 mM
NaCl and 1 mM EDTA. The peak fractions (0.5 ml each) of
large molecular weight DNA were pooled and ethanol
precipitated by addition of 1/10 volume 2 M NaOAC, pH 5, and
20 2.5 volumes cOla absolute ethanol.
3. Addition of EcoRI Linkers
The Sl-treated double-stranded cDNA (0.21J~g) was incubated
in buffer (60 mM Tris-HCl, pH 7.5; 8 mM MgCl; 5 mM
dithiothreitol, 1 mM ATP and 5 mM of each deoxynucleoside
.
.
~ -33-
~ . -
.. . _ _ _ . _ . _ .. . . . . . . . . .
: - . ~ .
,
,
: .

1 ~ 73 ~ ~
triphosphate) with 9 units of E. coli DNA polymerase ~ at 10
C for 10 m~nutes and then placed on ice. This blunt- ended
double ~tranded cDNA was next incubated in 65 mM Tris-HCl, pH
7.5; 6 mN Mg C12; 5 mM dithiothreitol; 1 mM ATP, with 160
pmoles of 32P-labelled EcoRI synthetic linker (lOOx excess
over cDNA ends) and 4 blunt-end units of T4 DNA ligase at 15
C for 5 hours, cooled on ice, treated with EcoRI restriction
endonuclease (New England Biolabs, 9 units) in 100 mM
Tris-HCl, pH 7.5, 50 mM NaCl, 5.6 mM MgC12 at 37 C for 4
10 hours 45 minutes and then phenol extracted. The reaction was
fractionated on a Biogel A-150m column (0.7 cm x 31.5 cm).
Fractions ~0.5 ml each) containing high molecular weight DNA
were pooled and ethanol precipitated.
This double stranded cDNA with EcoRI cohesive termini was
then ligated to fl phage CGF4 doùble-stranded DNA which had
been cut open with EcoRI restriction endonuclease and treated
with calf intestinal alkaline phosphatase by the method of H.
Goodman and R. J. MacDonald [Goodman, H. M. and MacDonald, R.
J., Methods in EnzYmol. 68, 75-91 (1979)~ to remove the
terminal phosphates: The ligation reaction contained 60 mM
Tris-HCl, pH 7.5; 6 mM MgC12; 7 mM dithiothreitol; 0.12J~g
double-stranded cDNA; 1.2~9 CGF4 DNA; O.S mM ATP and 450
cohesive end units of T4 DNA ligase. Ligation was for 19
hours at 15 C.
-34-
' ~, . ''
, ,. . . . . . '
, ~' : ' : . '~ - . -
.

1~ 73 ~
4. Transfection of E. coli DB4548 with recombinant CGF4 DNA
E. coli strain CGE6 (DB4548; hsdR , hsdM , sup E, sup F,
~1 , met ) was grown in 150 ml tryptone broth at 37 C
with shaking and harvested at OD700=0.5 by centrifuqation
at 7,000 rpm for 10 minutes at 4 C. The cells were
resuspended in 70 ml ice cold 50 mM CaC12 and allowed to
sït at 0 C for 30 minutes. The suspension was then
centrifuged at 7,000 rpm for 10 minutes at 4 C and
resuspended in 3 ml ice cold 50 mM CaC12. After standing
10 at 0 C for 2 hours the cells were used for transfection.
Either lJ~l or 2 ~1 of 1:40 dilution of ligation reaction in
50 mM Tris-HCl, pH 7.5, was added to each of 12 tubes
containing 50 ml sterile 50 mM Tris-HCl, pB 7.5. One-tenth
milliliter of the CaC12-treated cells was added to each
tube and the mixtures set on ice for 30 minutes. After
warming to 37 C for 2 minutes, 0.2 ml of CGE5 (JM101: J.
Messing (1979), F'traD36 proAB lacIZVM15 in a v(lac pro) SupE
thi background) overnight culture and 3 ml of 0.~ soft
agar were added, and the mixture poured into tryptone agar
plates. Incubation at 37 C overnight produced over 3000
plaques.
..

~ ~ ~ 3 ~8~
5. Identification of a recombinant-CGF4 carrying the bovine
growth hormone sequence
The plaques were transferred to nitrocelluloses and probed as
described by Benton and Davis lBenton, W. D. and Davis, R.
W., Science 196, 180-182 (1977] using a 32P-labelled BGH
cDNA. The phages which hybridize intensely to the cDNA probe
were picked from the plates and stored in TY medium at 4 C.
Samples of the intact phage were amplified by growth
overnight on CGE5 cells, harvested by centrifugation, and
~ubjected to electrophoresis in a 0.6~ agarose gel containing
0.37 M Tris-glycine, pH 9.5, and stained with ethidium
bromide after treatment in 0.2 N NaOH for one hour and
neutralization in 0.5 M Tris-HCl, pH 7.4. The migration is
inversely proportional to the log of the size of the phage
DNA and allowed selection of about 45 phages carrying
inserted BGH DNA of size of 600 to 1200 base pairs. Single
~tranded DNA was prepared by the method of Horiuchi, et al.
lHoriuchi, R., Vovis, G. F. and Zinder, N. D., J. Biol. Chem.
249, 543-552 ~1974)1 and hybrid selection was carried out.
The eluted RNA was translated in a reticulocyte lysate system
by the method of Pelham and Jackson [Pelham, H. R. D. and
Jackson, R. J., Eur. J. 8iochem. 67, 247-256] and alalysis of
the protein products revealed the production of authentic
immunoprecipitable BGH. Double-stranded RFI DNA was prepared
from the phages by the method of Moses, et al. IMoses, P.B.,
.. ~ .
~ -36-
, . ,
. ~ ~ -- . . .
.:'
.~,
,

~ ~ 7~
Boeke, J.D., Horiuchi, K. and Zinder, N. D., viroloqy 104,
267-273 tl980)]. Each DNA was cut with EcoRI and PstI
restriction endon~cleases and the resulting fragments
analyzed on an agarose gel to confirm that the insert
contained a P I site. One of the phage DNA's which had a
segment of about 850 base pairs (bp) was chosen for further
study. ~he DNA insert was sequenced by the method of Maxam
and Gilbert [Maxam, A. M. and Gilbert, W., Methods in Enzymol.
68, 499-560 (1980)] as shown in Table 6.

TABLE 5
Eco RI
( 12 5 )
pr / ~ I
/
\ BGH
E. coli
c)rigin pCGSl 4 4 . ~
\ ~ _Cla I
' ~ ' / '
2~ \ . /
origin \ ~ /URA3
:
,~ .
'~ .
~ - 3 ~-
' ~' ' ' ~' . ~
,
- ,
~,~ ~ ; , : ' ' ,
' ' :

1~73~33 ` - -
~5o Vt ~o o ~o o, ~o o, ~ o o ~ ~o o U~ ~o ~
C t!~ C C!:l L ~ --~ 1) t~ ~ V ~
r0 V ~ t ~
~ ~ c ~~n~ ~ ~ ~ v~ ~ _
_ ~ L C,~ C ~ V~ S _
L ~_) C t_~ L t~ ~ C~ Cl 1-- ~n t~ ~ L 5_~
_ ~ O ~ ~ ~ O C~
~ ~ ~ t~ ~ ~: 0 ~ > t.!:l Q. t ~ _
o V~ CJ 1-- c ~ L ~ ~ ~ L l ~ ~ C!~ 1~1
r~ L t~ S i~ .c t~ 1
O O o ~ C~ o >~c~O V~ S o L ~ o ~ ~ o ~,1-- o 8
c~ _ t ~--8 ~ n8 r- ~ rl ~ ~
~,~ ~,~ ~ ~ c ~~ r~ r~ 1-- L ~
~C!~ _ C!~ C
1'0 ~S ~ L ~ o ~~ t!~ ~ L t~ ~ _.
_ t~ ~ o~ ~ L ~ _ ~S t.~ ~ ~
~t ~ ~ 0 ~ o ~ ~
~D ~ t!) L ~ L t_~ ~ ~ _ ~ ~ ~ ~ ~ ~ ~ ~_
~LIJ ~ E 1-- S ~ ~ ~L ~ L ~)
~ ~ O ~ . ~3 ~-- 3 ~ ~
~ Y 1-- >~ S ~ O ~ GC~
~ LO~ C~ 3~ E
8 ~ ~ ~ ~ ~ 4 _ ~
" ~ ,~ ~ o ~ C~ o ~o ~ o ~ t~ t~ ~ ~ o V~ o U~
0 ~~ ~ :~
h ~ ~ sG~ L ~L ~ ~ E ~ ~
t~ _ ~ L ~ ,t~ ~ Cl; C C~
~ ~ 0 0 t~ ~ ~ _ ~ V~t~ S ~'S 0
L 1~ ~ 3 ~ v~ 3 ~
C~ ~1--L 1-- L ~ ~C_~ L
s ~ ~ ~ ~ ~ s
~t '~~ ~ --3~ ~ t
t
o ~ ~ o ~ t~0 t,~ ~ ~ ~ t!:J L ~ vt C~ C!S
, ,~
. .
,
'. ~ '
`. ~ . ' `' ' '
' '
.' ~''
'
,

1~73~38;~
6. Expression of BG~ in Saccharomvces cerevisiae
A plasmid, pCGS144, as seen in ~able 5, designed to
facilitate obtaining expression of BGH in yeast was
constructed. In order to produce the BGH in yeast, an ATG
initiation codon was incorporated at the 5'-side of the first
amino acid (phenylalanine). Based on the fact that HaeII
cuts at the 3'-side of the first codon, a HaeII digest was
carried out to open the 5'-end at the Phe codon. The
cohesive ends were trimmed back by treating the DNA with 4
units E. coli DNA polymerase I (Klenow fragment) in the
presence of O.S mM dATP in 6.6 mM Tris-HCl, pH 7.5; 6.6 mM
NaCl; 6.6 mM MgC12 and 66 mM dithiothreitol, for 30 minutes
at room temperature, and then blunt-ended with Sl nuclease..
A ClaI synthetic linker (CATCGATG) containing the ATG
initiation codon was ligated onto the blunt-ended fragment in
66 mM Tris-HCl, pH 7.5; 10 mM MgC12; 10 mM 2-mercapto-
ethanol; lmM ATP with 500 pmole 32P-ClaI linker; 4 pmoles
DNA ~20 ~g) and 4 blunt-end units of T4 DNA ligase at 17 C
overnight. This ligation created an ATG initiation codon and
restored the first codon TGT. ClaI polylinker was removed by
treating the fragment with 20 units restriction endonuclease
ClaI for 3 hours at 37 C in a 20J41 reaction containing 10
mM Tris-HCl, pH 7.5; 10 mM MgC12; and 0.1 mg/ml bovine
serum albumin. The resulting fragment was cloned into the
ClaI site of plasmid pBR322. The plasmid ~10J~9) was cut
-40-
.
.:' . .
.,:. . . : ,
. . ,
'
-
,

~73~a~
with the restriction endonuclease ClaI (New England Biolabs,
20 units) for 2 hours at 37 C in a 20~1 reaction containing
lOmM Tris-HCl, pH 7.5; 10 mM MgC12 and 0.1 mg/ml bovine
serum albumin. The preparation of restriction cut plasmid
was phenol extracted, ethanol precipitated and treated with
calf intestinal phosphatase by the method of H. Goodman and
R. J. MacDonald [Goodman, H. M. and MacDonald, R. J., Methods
in Enzymology 68, 75-91 (1979)] to remove the terminal
phosphates. Approximately O.S pmole of the ClaI fragment and
0.3 pmole of the ClaI cut plasmid were ligated together at
15 C for 3 hours in a 20J~1 reaction containing 66 mM
Tris-HCl, pH 7.5; 6 mM MgC12; 10 mM dithiothreitol; lmM
ATP; and T4 DNA ligase (New England Biolabs, 300 units)
creating plasmid pCGE27.
Transformation-competent E. coli strain CGE43 (LG90;
F ~(lac-pro)Xlll) was prepared as described previously for
CGE6, and 5 ~1 of the ligated DNA was mixed with
200 ~1 of the cells for 30 minutes at 0 C, heat treated at
37 C for 2 minutes, incubated at room temperature for 10
minutes, and diluted five-fold with fresh tryptone broth.
After incubation for 30 minutes at 37~ C with shaking, cells
were plated on tryptone plates containing ampicillin (20
~g/ml). Ampicillin-resistant colonies were picked, and the
plasmid DNA was prepared and analyzed by restriction enzyme
digestion. By these criteria several cells carried the
desired plasmid, pCGE27. Plasmid pCGE27 DNA (10~9) was
...

~ 73~8~
cut with the restr;ction endonuclease HindlII (Collaborative
Research, Inc., 12 units) for 2 hours at 37 C in a 20~1
reacti~n containing 10 mM Tris-HCl, pH 7.5; 10 mM MgC12; 60
~M NaCl; and 0.1 mg/ml bovine serum alb~min). This DNA was
next digested witb the end~nuclease EcoRI (Collaborative
Research, Inc., 15 units~ for 3 hours at 37 C in a 20 ~1
reaction containing 100 mM Tris-HCl, pH 7.6; lOmM MgC12; 50
mM NaCl; and 1 mg/ml bovine serum albumin. The restr;ction
cut DNA was trimmed back with E. coli DNA polymerase I
(Rlenow fragment) in the presence of 0.5 mM dTTP and made
blunt-ended with Sl nuclease as described previously. The
DNA was then phenol extracted, ethanol precipitated,
redissolved in water and applied to a preparative horizontal
1.5~ agarose gel. After electrophoresis for 2 to 3 hours in
40 mM Tris-acetate, pH 7.2, the gel was stained with ethidium
bromide and examined under long wavelength ultraviolet
light. The digested DNA was extracted by freezing and
thawing the gel pieces [Thuring, et al., Anal. Biochem 66,
213 ~1975)1. The DNA fragment was ethanol-precipitated and
redissolved in water. A plasmid (pGL101; 20 ~9) containing
95 base pairs of PlaC inserted at EcoRI/PvuII site of
pBR322 was cut with the restriction endonuclease PvuII (New
England Biolabs, 24 units) for 6 minutes at 37 C. The
restriction cut DNA was phenol extracted, ethanol
precipitated, and redissolved in water. This PvuII opened
vector was analyzed by gel electrophoresis and excised from
- -42-
.
' ' ~
' "'' .' ' ' ' '
,: - :
'

i ~ 7~
the gel (see above). Approximately 0.25 pmole of the DNA
fragment coding for sGH was ligated into plasmid pGL101
opened at its PvuII site tsee above) for 4 hours at 14 C in
a 20 ~ reaction containing 66 mM Tris-HCl, pH 7.6; 6.6 mM
MgC12; 10 mM dithiothreitol; 1 mM ATP and T4 DNA ligase
(New England Biolabs, 300 units). Transformation-competent
E. coli strain CGE43 cells were prepared exactly as described
àbove, and 5 ~1 of the ligated DNA was mixed with 100~1 of
the cells for 30 minutes at 0 C, heat treated at 37 C for
2-5 min~tes, and diluted ten-fold with fresh tryptone broth.
After incubation for 30 minutes at 37 C with shaking, cells
were plated on tryptone plates containing ampicillin (20
,~g/ml). Ampicillin-resistant colonies were picked, and the
plasmid DNA was prepared and analyzed by restriction enzyme
digestion for the correct orientation. By these criteria
several strains carried the desired plasmid, pCGE22, which
contained the PLAC-phe-BGH gene-
The fragment containing the gene for BGH was isolatedfrom plasmid pCGE22 (30J~gS by partial cutting the plasmid
with restricton endonuclease PvuII and PstI at 37 C as
above. The restriction cut DNA was phenol extracted, ethanol
precipitated, redissolved in water and applied to a
preparative 0.5~ agarose gel. After electrophoresis in 40 mM
Tris-acetate, pH 7.2, the gel was stained with ethidium
bromide and examined under long wavelength ultraviolet
light. ~he band was excised and the DNA extraced by freezing
-43-

~738~3
and thawing the gel pieces IThuring, et al., Anal. Biochem.
66, 213 (1975)1. The DNA fragment was ethanol precipitated
and redissolved in water. Approximately 0.5 pmole of the
PvuII/PstI fragment was ligated into plasmid pCGE41 opened at
its EcoRI site adjacent to the PLAC/'~ region and at Pstl
site. ~he EcoRI site was filled in with E. coli DNA
polymerase I. Ligation was carried out for 2.5 hours at 14
C in a 20J~1 reaction containing 66 mM Tris-Hcl, pH 7.6; 6.6
mM MqC12; 10 mM dithiothreitol; 1 mM ATP and T4 DNA ligase
(Collaborative Research, Inc., lO units). The ligated DNA
was used to transform competent E. coli cells which were
verified to contain the desired plasmid, pCGE51.
The plasmid, pCGE27, was cut with ClaI restriction
enzyme, and the resulting fragment made blunt-ended with Sl
nuclease. A SalI synthetic linker (GGTCGACC) was litaged
onto the blunt-ended fragment. SalI polylinker was removed
by treatment with 20 units restriction endonuclease SalI. It
was then cut with Pstl. The resulting fragment together with
the PstI/XhoI BGH' 'Z fragment of pCGE51 were cloned into the
20 yeast shuttle vector pCGS40 as descrlbed previously.
The plasmid, pCGS40, comprises most of pBR322 containing
a DNA replication origin and B-lactamase yene for selection
in E. coli, with a l.6 kilobase fragment of the yeast
plasmid containing an initiation site for replication in
- yeast, with a l.l kilobase fragment from the yeast
chromosomal DNA carrying a URA3 gene for selection in yeast
-44-
.~ .
,~ ' .
.. ..
.. . . ~ .
,

1273f~3
and with a 0.9 kilobase fragment from yeast chromosomal DNA
containing the SUC2 promoter of the yeast invertase gene.
The plasmid pCGS40 was constructed by first cutting 60~9 of
plasmid pRB118 lCarlson, M. and Botstein, D., Cell 28,
145-154 ~1982)] with restriction endonuclease HindIII for 30
minutes at 37 C and then with restriction endonuclease EcoRI
(see above). The restricti~n cut DNA was phenol extracted,
ethanol precipitated, redissolved in water and purified by
gel electrophoresis. The digested EcoRI to HindlII 0.9
kilobase band which contains the promoter for the SUC2 gene
was excised and the DNA extracted by glass beads.
[Vogelstein, B. and Gillespie, D., PNAS 76, 615-619 (1979).]
The 0.9 kilobase DNA fragment containing the SUC2 promoter
was placed on the~ plasmid YIp5 (a shuttle vector which can be
selected for and maintained in yeast due to the presence of
the URA3 gene or E. coli due to the presence of the AmP
gene). The resulting plasmid, pCGS46, obtained after
ligation and transformation was purified and its structure
verified. The plasmid pCGS40 was constructed by cutting the
plasmid pCGS46 with restriction endonuclease PvuII for 1 hour
at 37 C. A 1.56 kilobase fragment of 2J~ DNA from plasmid
YEpl3, obtained from R. Davis, Stanford University, was
removed by cutting YEpl3 with HPaI and HindIII. The
resulting fragment was gel purified, phenol extracted,
ethanol precipitated, and treated with T4 DNA polymerase (see
above) in order to create blunt ends at the HindIIl
.
:
.' , . . . . .
. ' ' ' , ' ' ' ' .

1;~73~8;~
restr;ction c~t. After phenol extraction and ethanol
precipitation, the PvuII cut ~NA and blunt-ended 2~ DNA
fragment were purified by qel electr~phoresis and ligated
together overnight. The resulting plasmid, pC~S40, can be
grown and its presence can be selected for in either E. coli
or Saccharomyces cerevisiae. Following transformation and
restriction analyses, the desired plasmid, pCGS75, was
obtained containing BGH' 'Z.
The plasmid, pCGS75, was cut with SalI and then rendered
blunt-ended by treatment with E. coli DNA polymerase I. The
blunt-ended DNA was then cut with Xbal and the fragment gel
purified. This same plasmid was also cut with EcoRI/XbaI to
produce a fragment which upon ligation with the previously
isolated SalI-blunt-ended/XbaI fragment and an EcoRI/BamHI
fragment of pBM125 yielded pCGS118 containing PGALl BGH' 'Z
on a yeast shuttle vector. The PGALl promoter ~820 bp)
came from pBM125 (courtesy of R. Davis, Stanford University)
which was cut with BamHI, filled in with E. coli DNA
polymerase I then cut with EcoRI.
The construction of pCGS144 containing the BGH gene
promoted by PGALl was accomplished by a tri-molecular
reaction. ~he GALl promoter and part of the BGH gene were
removed from pCGS118 by restriction with XbaI and PstI. The
rest of BGH was obtained by cutting pCGE27 with PstI and
- ClaI. These gel pruified fragments were ligated with a
XbaI/ClaI fragment of pCGS57 which contained part of the 2
and the URA3 gene.
-46-
, : . , ' .
.
- :

~ ~3 ~S~3
The yeast strain CGY150 (MATa, leu 2-3, leu 2-112, ura
8-50) was transformed with the BGH plasmid DNA by the method
of A. Hinnen, J. B. Hicks, and G. Fink tHinnen, A., Hicks, J.
B. and Fink, G. ~., Proc. Nat. Acad. sci. USA 75, 1929-1933
(1978)1. Yeast transformants CGY196, capable of growth
without added uracil due to the presence of URA3 gene on the
plasmid, were picked. (Strain CGY196 bearing plasmid pCGS144
is on deposit with the American Type Culture Collection
(ATCC), Accession number 20643, deposited September, 1982.)
The yeast cells were grown at 30~ C with agitation in a
medium containing 6.7 9/1 yeast nitrogen base, 30 mq/l
L-leucine and 2~ galactose. The synthesis of BGH was induced
due to the presence of galactose. After growing to Klett =
50 at 30 C with agitation, the cells were collected by
centrifugation, resuspended in 0.25 ml 0.05 M Tris-HCl, pH
7.6, 20% glycerol and 1 mM PMSF, and frozen at -20 C. The
cells were disrupted by glass beads by the method of M Rose,
et al. lRose, M., Casadaban, M. J. and Botstein, D., Proc.
Nat. Acad. Sci. US~ 78, 2460-2464 (1981)] and the amount of
20 BGH activity in the cellular extract was determined by
immunoprecipitation.
The seguencing information for the bovine growth hormone
gene produoed is shown in ~able 6.
-47-
: .
", ~
,,; ,
-,

~ ~ 7~
EXAMPLE 2
_
Production of Interferon
1. Isolation of IFN mRNA
3.55 grams of Sendai virus induced lymphocytes were disrupted
by means of a Dounce homogenizer into 40 ml of cold buffer
(10 C) consisting of 50 mM NaOAc, pH 5.2; 6 M guanidine HCl;
and 0.1 M 2-mercaptoethanol. The resulting solution was
sonicated at 60W pulsed power for 2x30 seconds and then
layered onto 3 ml shelves of 5.8 M CsCl, pH 7.2, containing
0.1 M EDTA. The material was centrifuged at 15 C in a
Beckman Type 50 Ti rotor at 40,000 rpm overnight. The pellet
was resuspended on ice for 20 minutes in 6.6 ml of the above
cold buffer plus 20 mM EDTA, and then treated with 3.3 ml of
ice-cold absolute ethanol. After 1 hour at -20 C, the
precipitate was pelleted by a centrifugation at 8,000 rpm for
20 minutes at -10 C. The pellet was resuspended two times
in 18 ml of the preceding buffer, treated with 9 ml of ice
cold absolute ethanol, chilled one hour at -20 C and the
pellet collected as decribed previously. The final pellet
20 was resuspended in 8 ml of 0.1 M EDTA with heating at 60 C,
and then 0.1 volume of 2M NaOAC, pH 5.0, and 2 volumes of
ice-cold absolute ethanol were added and the solution placed
at -20 overnight. The RNA precipitate was collected by
-48-
': ~ ., . - .:
.
~ . ~ - ' :

1i~7388;~
centrifugation at 8,000 rpm for 20 minutes at -10 C, and was
dissolved in ~ ml water. The yield was 396 mg RNA. ~he RNA
solution was diluted with S ml of 2x concentratea binding
buffer (20 mM Tris-HCL, pH 7.5; 2mM EDTA, pH 7.0 0.4~ SDS;
and 0.24 M NaCl). The RNA was applied to a 1 ml oligo-dT-
cellulose column, the column was washed with lx concentrated
binding buffer and then the poly A-containing RNA (mRNA) was
eluted by washing the column with binding buffer containing
no NaCl. About 39 mg of poly A-containing RNA was obtained.
A portion of the poly A-containing RNA was translated in
vitr_ in a rabbit reticulocyte lysate system [Pelham, H.R.B.
and Jackson, R.J., Eur. J. Biochem. 67, 247-256 (1976)] to
confirm the isolation of mRNA coding for interferon.
2. Preparation of double-stranded copy DNA (cDNA)
About 2.5~9 of cDNA was synthesized from 25J4g of the
lymphocyte poly A-containing RNA by incubation for one hour
at 42 C in 50 mM Tris-~cl, pH 8.3; 100 mM RCl; 8mM MgC12;
0.4 mM dithiothreitol; 1.2 mM each dATP, dGTP and dTTP; and
20J~g/ml oligo (-dT)12 18~ containing 100 units reverse
transcriptase and 0.25 mM d-32P-dCTP(1.8 Ci/mmole). After
heating the reaction mixture at 100 C for 3.5 minutes, quick
- chilling on ice for approximately 3 minutes and removing the
precipitated protein by centrifugation, to the supernatant
was added Hepes-NaOH, p8 6.9, to 100 mM: MgC12
'
~ -49-
,
,
. "'''~ ' , ': ' ' '
, ~ , . ' ' ~ -
' ' : ,, . '

1~73~8;~
to 5 mM; dithiothreitol to 0.5 mM; and deoxynucleoside
tripho~phates as above. Incubation of this mixture with 300
units of E. coli DNA polymerase I for 2.5 hours at 15 C
produced l.8~9 of double-stranded CDNA. The DNA was phenol
extracted, separated from unincorporated triphosphates by
chromatography on Sephadex G-100 (13 ml column, 0.68 cm x 37
cm, eluted with 20 mM Tris-HCl, p~ 7.5, 3.5 mM EDTA) and
ethanol precipitated overnight at -20 C by addition of l/10
volume 2 M NaOAc, pH 5, and 2.5 volumes cold ethanol. The
double-stranded cDNA was then treated with 8,000 units of Sl
nuclease at 37 C for one hour in buffer (0.3 M NaCl, 30 mM
NaOAc, pH 4.6, 3 mM ZnS04). The reaction was terminated by
addition of EDTA to l0 mM, and Tris-HCl, pH 8.3, to 200 mM,
and the mixture applied to a Biogel A-150m column (0.7 cm x
35 cm) equilibrated and eluted with 10 mM Tris -HCl, pH 7.5,
250 mM NaCl and 1 mM EDTA. The peak fractions (0.5 ml each)
of large molecular weight DNA were pooled and ethanol
precipitated by addition of l/10 volume 2 M NaOAC, p~ 5, and
2.5 volumes cold absolute ethanol.
3. Addition of HindIlI Linkers
The Sl-treated double-stranded cDNA (0.21 ~g) was incubated
in buffer (60 mM Tris-HCl, pH 7.5; 8 mM MgCl; 5 mM
dithiothreitol, 1 mM ATP and 1 mM of each deoxynucleoside
-50-
.:
': ~ ' ` '

~ ~'7~
triphosphate) with 9 units of E. coli DNA polymerase I at
10 C for 10 minutes and then placed on ~ce. This blunt-
ended double stranded cDNA was next incubated in 65 mM
Tris-HCl, pH 7.5; MgC12; 5 mM dithiothreitol; 1 mM ATP,
with 160 pmoles of 32P-'abelled HindIII ~ynthetic linker
(100 x excess over cDNA ends) and 4 blunt-end units of T4 DNA
ligase at 15~ C for 5 minutes, cooled on ice, heat treated to
inactivate the ligase, treated with HindIII restriction
endonuclease (New England Biolabs, 9 units) in 5.6 mM
Tris-HCl, pH 7.5, 5.6 mM MgC12 at 37 C for 4 hours 45
minutes and then phenol extracted. The reaction was
fractionated on a Biogel ~-150m column (0.7 cm x 31.5 cm).
~ractions (0.5 ml each) containing high molecular weight DNA
were pooled and ethanol precipitated.
This double stranded cDNA with HindIII cohesive termini
was then ligated to fl phage CGF4 double-stranded DNA which
had been cut open with HindlII restriction endonuclease and
treated with calf intestinal alkaline phosphatase by the
method of H. Goodman and R. J. MacDonald [Goodman, H. M. and
MacDonald, R. J., Methods in Enzvmol. 68, 75-91 (1979)] to
remove the terminal phosphates (Note: In order to produce
phage CGE4, fl phage R229 [Boeke, J. D., Mol. Gen. Genet.
181, 288-291 (1981)] was cut with EcoRI endonuclease,
rendered blunt ended with T4 DNA polymerase and ligated with
HindIII synthetic oligonucleotide linkers from Collaborative
Research, Inc. of Eexington, Massachusetts.) The ligation
' , ' , ~ ' ' - :
. -. ' . ' ~
.

~;~7~
reaction contained 60 mM Tris-HCl, pH 7.5; 6 m~ MgC12; 7 mM
dithiothreitol; 0.12 ~9 double-stranded cDNA; 1.2,yg CGF4
DNA; 0.5 mM ATP and 450 cohesive end units of T4 DNA ligase.
Ligation was for 19 hours at 15- C.
4. Transfection of E. coli DB4548 with recombinant CGF4 DNA
. _
E. coli strain CGE6 (DB4548; hsdR , hsdM , sup E~ sup F,
Bl , met ) was yrown in 150 ml tryptone broth at 37~ C
with shaking and harvested at OD700=0.5 by centrifugation
at 7,000 rpm for 10 minutes at 4~ C. The cells were
10 resuspended in 70 ml ice cold 50 mM CaC12 and allowed to
sit at 0 C for 30 minutes. The suspension was then
centrifuged at 7,000 rpm for 10 minutes at 4 C and
resuspended in 3 ml ice cold 50 mM CaC12. After stan~ing
at 0 C for 2 hours the cells were used for transfection.
Either 1 ~1 or 2 J41 of 1:40 dilution of ligation reaction in
50 mM Tris-HCl, pH 7.5, was added to each of 12 tubes
containing 50~1 sterile 50 mM Tris-HCl, pH 7.5. One-tenth
- milliliter of the CaC12-treated cells was added to each
tube and the mixtures set on ice for 30 minutes. After
warming to 37- C for 2 minutes, 0.2 ml of CGE5 (JM101: J.
Messing (1979), F'traD36 proAB lacIZVM15 in a ~(lac pro) SupE
thi background) overnight culture and 3 ml of 0.7~ soft
agar were added, and the mixture poured into tryptone agar
plates. Incubation at 37- C overni~ht produced over 1280
plaques.
-52-
.

1~ 7~
5. Identification of a recombinant-CGF4 carrying the
leukocyte interferon ~equence
The plaques were transferred to nitrocelluloses and probed as
described by Benton and Davis [Benton, W. D. and Davis, R.
W., _ience 196, 180-182 (1977] using a 2P-labelled
synthetic oligonucleotide (with the sequence,
CATGATTTCTGCTCTGAC, Collaborative Research, Inc.) which
corresponds to a known segment of LeIFN. The oligonucleotide
(1 ~g) was kinased with 0.5 mC ~-32P-ATP using 6 units of
T4 polynucleotide kinase (P-L Biochemicals) in a 20 ~1
reaction containing 66 mM Tris-HCl, pH 7.5, and 10 mM
MgC12. The phage which hybridized intensely to the
synthetic oligonucleotide probe were picked from the plates
and stored in TY medium at 4- C. Samples of the intact phage
were amplified by growth overnight on CGE5 cells, harvested
by centrifugation, and subjected to electrophoresis in a 0.6%
agarose gel containing 0.37 M Tris-glycine, pH 9.5, and
stained with ethidium bromide after treatment in 0.2 N NaQH
for one hour and neutralization in 0.5 M Tris-HCl, pH 7.4.
The migration is inversely proportional to the log of the
size of the phage DNA ana allowed selection of phage carrying
inserted IFN DNA of size of 1000 to 1200 base pairs. Double-
stranded RFl DNA was prepared from the phage by the ~ethod of
Moses et al. [Moses, P.B., Boeke, J.D., Horuchi, K. and
Zinder, N.D., Virology 104, 267-273 (1980)]. This DNA was
-53-

1.~7;~
cut with HindIII restriction endonuclease and the resulting
fragments analyzed on an agarose gel to confirm that the
insert was in the HindlII site and of the anticipated size.
One of the phage DNA's which has an insert of about 1200 base
pairs (bp) was chosen for further study. The DNA insert was
sequenced by the method of Maxam and Gilbert [Maxam, A. M.
and Gilbert, W., Methods in Enzymol 68, 499-560 (1980)~.

~7~8~3
TAB LE 7
GAL1
promoter
(125)
Eco RI ~
Hind III
"~ IFN-cl B '
Amp /
~d III
pCGS261
E. coli
origin
>~ ~
A3
'
'
~ ~ .
-5S-
. .
., . , ' . ,
"" - - ~- - ' ' : -

~L~t;~
6. Expression of LeIFN in Saccharo~yces cerevisiae
A plasmid, pCGS261, as seen in Table 7, designed to
facilitate obtaining expression of LeIFN in yeast was
constructed. In order to produce the LelFN in yeast, an ATG
initiation codon was incorporated at the 5'-side of the first
codon (TGT for cysteine) of mature, processed IFN. Based on
the fact that Sau~AI cuts at the 3'-side of the first codon,
an oligonucleotide (ACACATCGATGTGT) which is recognized by
ClaI and also contains thè ATG-TGT sequence was synthesized
by Collaborative Research, Inc. A Sau3Al fragment which
codes the amino acid residues 2 to 61 was purified by
digesting 30~g of the HindIII 1.2 kilobase fragment with 10
units Sau3Al restriction endonuclease in a 50 ~ 1 reaction
volume containing 10 mM Tris-HCl, pH 7.5; 10 mM MgC12; and
60 mM NaCl for 4 hours at 37 C. The DNA fragment was
purified by polyacrylamide gel electrophoresis. The DNA was
phenol extracted and precipitated with ice-cold absolute
ethanol. The cohesive ends were filled in by treating the
DNA with 4 units E. coli DNA Polymerase I Klenow fragment and
0.1 mM each nucleoside triphosphate in 66 mM Tris-HCl, pH
7.5 66 mM NaCl; 66 m~ MgC12 and 66 mM dithiothreitol, for
30 minutes at room temperature.
~56-
:
.

~ ~73~
The above synthetic oligonucleotide wa~ ligated onto the
Sau3Al fragment in 66 mM Tris-HCl, p~ 7.5; 10 mM MgC12; 10
mM 2-mercaptoethanol; lmM ATP with 500 pmole
32P-oligonucleotide (5~yg); 4 p~oles DNA (20 ~g) and 4
blunt-end units of T4 DNA ligase at 17- C overnight. This
ligdtion created an ATG initiation codon and restored the
first codon TGT. ClaI polylinker was removed by treating the
fragment with 20 units restriction endonuclease ClaI ~or 3
hours at 37 C in a 20 ~1 reaction containing 10 mM Tris-HCl,
pH 7.5; 10 mM MgC12; and 1 mg/ml bovine serum albumin. The
resulting fragment was cloned into the ClaI site of plasmid
pBR322. The plasmid (lOJ~g) was cut with the restriction
endonuclease ClaI (New England Biolabs, 20 units) for 2 hours
at 37- C in a 20 ~1 reaction containing lOmM Tris-HCl, pH
7.5: lO mM MgC12 and 1 mg/ml bovine serum albumin. The
preparation of restriction cut plasmid was phenol extracted,
ethanol precipitated and treated with calf intestinal
phosphatase by the method of H. Gbodman and R. J. MacDonald
~Goodman, ~. M. and MacDonald, R. J., Methods in Enzymology
68, 75-91 (1979)] to remove the terminal phosphates.
Approximately 0.5 pmole of the ClaI fragment and 0.3 pmole of
the ClaI cut plasmid were ligated together at 15- C for 3
hours in a 20 ~1 reaction containing 66 mM Tris-HCl, pH 7.5;
6 mM MgC12 10 mM dithiothreitol; lmM ATP; and T4 DNA
ligase (New England Biolabs, 300 units) creating plasmid
pCGE32. Transformation-competent E. coli
~,
-57-
. -
. .. . .
.
: . .

1;~73~38~
strain CGæ43 (LG90; F ~(lac-~_)xlll) was prepared as
described previously for CGE6, and 5 ~ 1 of the ligated DNA
was mixed with 200~ 1 of the cells for 30 minutes at 0- C,
heat treated at 37- C for 2 minutes, incubated at 18- C for
10 minutes, and diluted five-fold with fresh tryptone broth.
After incubation for 30 ~inutes at 37 C with shaking, cells
were plated on tryptone plates containing ampicillin
(20~g/ml). Ampicillin-resistant colonies were picked, and
the plasmid DNA was prepared and analyzed by restriction
enzyme digestion. By these criteria several cells carried
the desired plasmid, pC OE32.
The rest of the IFN gene was put back together by using
the EcoRI site located in the region coding for amino acid
residue 37. Plasmid pCGE32 DNA (10 ~ g) was cut with the
restriction endonuclease HindlII (Collaborative Research,
Inc., 12 units) for 2 hours at 37- C in a 20 ~1 reaction
containing 10 mM Tris-HCl, pH 7.5; 10 mM MgC12; 60 mM NaCl;
and 1 mg/ml bovine serum albumin). This DNA was next
digested with the endonuclease EcoRI (Collaborative Research,
Inc., 15 units) for 3 hours at 37- C in a 20~ 1 reaction
containing 100 mM Tris-HCl, pH 7.6; lOmM MgC12; 30 mM NaCl;
and 1 mg/ml bovine serum albumin. The restriction cut DNA
was phenol extracted, ethanol precipitated, redissolved in
water and applied to a preparative horizontal 1.5% agarose
gel. After electrophoresis for 2 to 3 hours in 40 mM
Tris-acetate, pH 7.2, the gel was stained with ethidium
.
-58-
.
, . . .
-:

bromide and examined under long wa~elength ultraviolet
light. The digested HindIII to EcoRI band whi~h codes the
ATG-TGT to amino acid residue 37 was excised and the DNA
extracted by freezing and thawing the gel pieces CThuring, et
al., Anal. Biochem 66, 213 tl975)]. m e DNA fragment was
ethanol-precipitated and redissolved in water. The plasmid
(20 ~g) containing the IFN clone was cut with the restriction
endonuclease HindIII (New England Biolabs, 180 units) for 2
hours at 37 C as above and then the DNA
(lZ ~g) was cut with the restriction endonuclease EcoRI (New
England Biolabs, 24 units) for 6 minutes at 37 C. The
restriction cut DNA was phenol extracted, ethanol
precipitated, and redissolved in water. This EcoRI to
HindIII fragment coding for amino acid residue 37 to the
3'-nontranslating region of IFN was analyzed by gel
electrophoresis and excised from the gel (see above).
Approximately 0.25 pmole of each fragment were ligated
together into plasmid pBR322 opened at its HindIII site (see
above) for 4 hours at 14- C in a 20 ~1 reaction containing 66
mM Tris-HCl, pH 7.6; 6.6 mM MgC12; 10 ~M dithiothreitol; 1
-- mM ATP and T4 DNA ligase (New England Biolabs, 300 units).
Transformation-competent E. coli strain C OE43 cells were
prepared exactly as described above, and 5J~1 of the ligated
DNA was mi~ed with lOOJ~l of the cells for 30 minutes at 0-
.~ C, heat treated at 37- C for 2.5 minutes, and diluted
~ ten-fold with fresh tryptone broth. After incubation
.:.
59-
- ,............. . .
' ~ ' . .' , '. ~ . :"
-
,
. ~ . .
.
'. ', ' ' . : .

1273~
~or 30 minutes at 37D C with shaking, cells were plated on
tryptone plates containing ampicillin (20 ~g/ml).
Ampicillin-resistant colonies were picked, and the plasmid
DNA was prepared and analyzed by restriction enzyme
digestion. By these criteria several strains carried the
desired plasmid, pC OE38.
A HindIII site was constructed in pCGS109 -~hich is a
standard shuttle vector (pCGS42) with PGALl inserted
between the EcoRI and BamHl sites. The vector, pCGS109, was
cut with BamRl restriction enzyme, digested with Sl nuclease
to remove cohesive ends making it blunt-ended and then
ligating on HindIII linker. The vector was treated with
~indIII restriction enzyme and then the cohesive ends were
ligated together to produce the vector ~CGS135. The 1.1
kilobase HindIII fragment containing the gene for LeIFN was
isolated from plasmid pCGE38 (30J~g) by cutting the plasmid
with restricton endonuclease HindIII for 1.5 hours at 37- C
; as above. The restriction cut DNA was phenol extracted,
ethanol precipitated, redissolved in water and applied to a
preparative 1% agarose gel. After electrophoresis in 40 mM
Tris-acetate, pH 7.2, the gel was stained with ethidium
bromide and examined under long wavelength ultraviolet
light. The 1.1 kilobase band was excised and the DNA
extraced by freezing and thawing the gel pieces CThuring, et
al., Anal. Biochem. 66, 213 (1975)]. The DNA fragment was
ethanol precipitated and redissolved in water. Approximately
~ ' .
-60-
'- '' :.,
.
- ,
- : :
.

1i~73~83
0.2J~g of the HindIII fragment was ligated into plasmid
pCGs135 (l~g) opened at its HindIII site adjacent to the
PGAL1 region. Ligation of the vector and IFN fragment was
carried out at 14^ C in a 20Jy1 reaction containing 66 mM
Tris-Hcl, pH 7.6; 6.6 mM MgC12; 10 mM dithiothreitol; 1 mM
ATP and T4 DNA ligase (Collaborative Research, ~c., 10
units).
The yeast strain CGY528 (~ ura 3-52, his 4-29, pep 4-3,
GAL+) was transformed with the plasmid DNA by the method of
A. Hinnen, J. B. Hicks, and G. Fink CHinnen, A., Hicks, J. B.
and Fink, G. F., Proc. Nat. Acad. Sci. USA 75, 1929-1933
(1978)]. Yeast transformant CGY528, capable of growth
without added uracil due to the presence of URA3 gene on the
plasmid was picked. (Strain CGY528 bearing plasmid pCGS261
is on deposit with the American Type Culture Collection
(ATCC), Accession Number 20663, deposited February, 1983.)
The yeast cells were grown at 30- C with agitation in a
medium containing 6.7 g/l yeast nitrogen base, 20~g/1
histidine and 2S galactose. m e synthesis of interferon was
verified by collecting cells grown to ~lett = 50 (107
cells/ml) by centrifugation; resuspended in 0.25 ml 0.05 M
Tris-HCl, pH 7.6, 20~ glycerol and 1 mM PMSF, and frozen at
-20- C. The cells were disrupted by glass beads by the
method of M Rose, et al. tRose, M., Casadaban, M. J. and
Botstein, D., Proc. Nat. Acad. Sci. USA 78, 2460-2464 (1981)]
-61-
- . ~ - .. . .
-
. ~ '. ~ '' ' ' ~ ' -

~73~33
and the amount of interferon activity in the cellular extract
was determined by conventional methods to he 105 units/mg
of soluble protein.
The sequencing information for the human leukocyte
interferon gene produced is shown in Table 8.
~ -62-
,",,,,., . :
.' ' .

lX~38~33
TABLE 8
R ~ G~g ~ Y~ y~ v
~, ~, E' ^~ ~3' ~ '~ V3~ ~ E 3 ~ E ~
,~ y~ ~oY~ ~os~ ~oY~ y~ 0 0= ~ y ~ s, ~ ~ O u
S ~ Y ~ U ~ æ ~ <
0 ~ U 0 0 ~ g
- ~ ` ~ ee~ e~ e ~ ~
O ~o ~ O ~ y O ~ u~u ~ ~ ~ ~ æ ~ ~ O _ ~
æ æ~ æ~ S ~ E,
~E~ ~Y= ~ Y~8 co~6 0tw y~ $~ ~~ Oo
~ ~a u o~<C O O ~ O O ~ ~ ~0 Uc Z ~o ~ ~ ~ g o
0~ y ~~j 5 ~lZ ~ ~LI~ ~ ~ $ ~ ~
jo ~ o ,o,~w O ~ ", u O .~ s
o O <~ x~ O ~t ~0 ~ ~ ~0 ~ ~a 3 ~ ~ ~
o~w ~;~a O 1 <o~ -U t ~ ~ ~a ~ e
-- 63 --
;;X~ ,
,
.' ' - : - ' :
~" ` : : ~' ' -.:

1;~7~
EXAMPLE 3
.
Production of Prorennin
1. Isolation of the RNA
Sto~ach tissue from milk-fed calves was obtained fresh
from a local slaughterhouse; the mucosa of the fourth stomach
was dissected away from the stomach wall and frozen in dry
ice. Twenty-one grams of the mucosal tissue was disrupted by
means of a blender into 200 ml of cold buffer (10 degrees C)
consisting of 50mM Tris.HCl, pH 7.5, 8M guanidine HCl, and
lmM dithiothreitol. Insoluble material was removed by -
centrifugation in a Sorvall SA-600 rotor at 10,000 rpm for 12
minutes. To the 200 ml of supernatant from the spin was
added 100 ml of ice cold absolute ethanol. After 1.5 hours
at -20 degrees C, the precipitate was pelleted by a
centrifugation at 3000 rpm for 30 minutes at -10 degrees C.
The pellet was dissolved in 40 ml of ice cold buffer (EGAD)
consiRting of 20mM EDTA, pH7, 20mM NaOAc, pH7, 8M
guanidine.HCl, and lmM dithiothreitol. Twenty milliliters of
cold absolute ethanol was added and the solution placed at
-20 degrees C for 45 minutes. The precipitate was pelleted
by centrifugation at 3000 rpm for 20 minutes at -10 degrees
C. The pellet was redissolved in 40 ml cold EGAD buffer and
.;- .
~ the precipitation with 20 ml cold ethanol, centrifugation and
`~'
-64-
: '
,
,', .
,~ , .. . . . .
~''~' ,
'
- , :

1;273~83
ledissolving the pellet in EGAD buffer was repeated two
additio~al times. Finally, the pellet was dissolved in 16 ml
of 20mM EDTA, pH 7 and extracted three times with
chloroform:isobutanol (4:1). Next, two volumes of 4.5M NaOAc
pH5.2 was added to the aqueous layer and the solution was
placed at -20 degrees C overnight. The RNA precipitate was
collected by centrifugation at 10,000 rpm for 25 minutes at
-10 degrees C, and was dissolved in 30 ml water. The yield
was 45 mg RNA. m e RNA was precipitated by addition of 1 ml
of 2M NaOAc pH5 and 75 ml absolute ethanol, followed by
incubation at -20 degrees C overnight. The RNA was pelleted
- by centrifuyation (10,000 rpm, 10 minutes -10 degrees C) and
redissolved in 20 ml water, heated to 60 degree~ C for 10
minutes, chilled rapidly on ice and diluted with 21 ml of 2x
concentrated binding buffer (20mM Tris HCl pH7,5, 2mM EDTA.
pH7, 0.4% SDS and 0.24M NaCl¦. The RNA was applied to a 4 ml
oligo-dT-cellulose column, the column was washed with 45 ml
of lY concentrated binding buffer, and then the poly
A-containing RNA was eluted by washing the column with
binding buffer containing no NaCl. About 1 mg of poly
A-containing RNA was obtained. A portion of the poly
A-containing RNA was translated in vitro in a rabbit
reticulocyte lysate system (H.R.B. Pelham and R.J. Jackson
tl976~ Eur J. Biochem. 67 247-256). The protein products
were analyzed on a 10% polyacrylamide gel. A single major
protein band was observed which was precipitated with rennin
..
~ ' ` ' ' :, ' ' '

'1~'73~3
Intiseru~ showing that rennin ~RNA i~ present in the poly
A-containing RNA~
2. Preparation of d oubl e-stranded copy DNA tcDNA)
About 8.7 ~ g of cDNA was synthesized from 20~9 of the
calf stomach poly A-containing RNA by incubation for one hour
at 42 degrees C in 50mM Tris HCl pH8.3, 100mM KCl, 8mM
MgC12, 0.4mM dithiothreitol, ln~l each deoxynucle~side
triphosphate, 20~ g/ml oligo(-dT)12 18 containing 100 units
reverse transcriptase and lCi/mmole ~ 2P-dCTP. After
heating the reaction mixture at 100 degrees C for 3 minutes,
chilling on ice for 3 minutes and removing the precipitated
protein by centrifugation, to half the ~upernatant material
was added Hepes-KOH pH6.9 to 100mM, MgC12 to 5mM,
dithiothreitol to 0.5mM, deoxynucleoside triphosphates to
0.125mM. Incubation of this mixture with 300 units of E.
coli DNA polymerase I for 2 hours at 16-C produced 8.6~g of
double-stranded cDNA. The DNA was phenol extrac'ed and
; separated from unincorporated triphosphates by chromatography
on Sephadex G-100 (12 ml column, 0.7 cm x 30 cm, eluted with
20mM Tris HCl pH 7.5, 0.5mM EDTA) and was ethanol
precipitated overnight at -20 degrees C by addition of 1/10
volume 2M NaOAc pH5, and 2.5 volumes cold ethanol. The
double-stranded cDNA t4.6 ~y) was then treated with 1000
units of Sl nuclease at 37 degree~
-66-
' , ' , : . :
- ' ' .
: .
. ~ ' ~ :.' ' . ' ' '
- . .
' ' ' ' '
'' '. ,.

` ` ~.;~7~
C for 1 hour in Buffer S (0.3M Na~l, 30mM NaOAc, pH4.6, 3mM
ZnS04). The reaction was terminated by addition of EDTA to
10mM, and Tris'HCl pH8.3 to 200mM, and the mixture applied
to a Biogel A-150m column (0.7cm x 33cm) equi~ibrated and
eluted with 10mM Tris'HCl pH7.5, lmM EDTA and 250mM NaCl.
The peak fractions (0.5ml each) of large molecular weight DNA
were pooled and et~anol precipitated by addition of 1/10
volume 2M NaOAC pH5 and 2.5 volumes cold absolute ethanol.
3. Addition of HindIII Linkers
The Sl-treated double-stranded cDNA (1.7~g) was
incubated in Buffer T (25mM Tris'HCl pH8, 6.6 mM MgC12,
O.5mM EDTA, 5mM 2-mercaptoethanol and 0.5mM of each
deoxynucleoside triphosphate) with 2 units of T4 DNA
polymerase at roo~ temperature for 30 minutes. m e material
was phenol extracted and ether extracted and ethanol
precipitated by addition of 1/10 volume 2M NaOAc pH5 and 2.5
volumes ethanol. This blunt-ended double-stranded cDNA was
next incubated in 66mM Tris'HCl pH7.6, 6.6mM MgC12, 5mM
; 2-mercaptoethanol, 0.5mM ATP, with 300 pmoles of
20 32P-labelled Hind 111 synthetic lin~er (100 x excess over
cD~A ends) and 9 blunt-end units of T4 DNA ligase at 12
degrees overnight.
~ he reaction was adjusted to 10mM EDTA pH8 and
fractionated on a Biogel A-150m column (0.7cm x 20cm).
;
-67-
... .
.': - ' , '
'
'

~ ;~73~
rractions (0.25~1 each) conta;ning high molecular weight DNA
were pooled and ethanol precipitated. This material was
treated with Hind III restriction endonuclease (9 unit~) in
5.6mM Tris HCl pH7.6, 5.6mM MgC12 at 37 degrees C for 45
min~tes, then phenol extracted, ether extracted and ethanol
precipitated by the addition of l/lO volume 1~ NaOAc pH5 and
2.5 volume, absolute ethanol. This double-stranded cDNA with
Hind III cohesive termini was then ligated to fl phage C OE4
double~stranded DNA which had been cut open with Hind III
restriction endonuclease and treated twice with calf
intestinal phosphatase by the method of H. Goodman and R.J.
MacDonald (H.M. Goodman and R.J. MacDonald ~1979] Methods in
Enzymology 68, 75-91) to remove the terminal pnosphates
(Note: In order to produce phage CGF4, fl phage R229 (J.D.
Boecke ~1981] Mol. Gen. Genet. 181, 288-291) was cut with
EcoR1 endonuclease, rendered blunt-ended with T4 DNA
polymerase and ligated with Hind III synthetic
; oligonucleotide linkers from Collaborative Research, Inc. of
Waltham, Massachusetts). The ligation reaction contained
20 66mM Tris-HCl pH7.6, 6.6mM MgC12, 5mM 2-mercapto-ethanol,
0.3J~g double-stranded cDNA, 0.2 ~ g CGF4 DNA, 0.5mM ATP and
300 cohesive-end units of T4 DNA ligase. Ligation was for
29 hours at 16 degrees C.
-68-
~.,
.'' :
. . .
.
-
' . - ' ` , .
- : ' . ~ '

lZ73~383
4 ~ransfection of E. coll ~NN45 with reco~binant-CGF4 DNA
E. coli strain CGE6 (~NN45; hsdR , hsdM~, sup E, sup
F, Bl , met ) was grown in tryptone broth at 37 deyrees C
with shaking and harvested at OD700 = 0.5 by centrifugation
at 7000 rpm for 10 minutes at 4 degrees C. The cells were
resuspended in ice cold 50mM CaC12 (one-half tne original
culture volume) and allowed to sit at 0 degrees C for 30
minutes. The suspension was then centrifuged at 7000 rpm for
10 minutes at 4 degrees C and resuspended in 1~20 the
original culture volume ice cold 50mM CaC12. After
standing at 0 degrees C for 60 minutes the cells were used
for transfection. One-half microliter of the 20~ 1 ligation
reaction was added to each of 8 tubes containing 50 ~1
~terile 50mM Tris HCl pH7.6. One-tenth milliliter of the
CaC12-treated cells was added to each tube and the mixtures
sat on ice for 30 minutes. After warming to 37c for two
minutes, 0.2 ml of a CGE5(JM101:J. Messing C1979], F'tra D36
pro AB lac IZVM15 in a v(lac pro) SupEthi bacXground)
overnight culture and 3ml of 0.7~ soft agar were added, and
the mixture poured onto eight tryptone agar plates.
lncubation at 37 degrees C overnight produced about 250
plaques per plate.
-69-

1~73~83
5. Identification of a Recombinant CGF4 carrying the rennin
coding sequence.
The plaques were transferred to nitrocellulose and p~obed
as described by Benton & Davis (W.D. Benton and R.W. Davis
tl977] Science l9G, 180-182) using P-labelled cDNA made
from the cal~-stomach poly A-containing RNA using ~32p_
dCTP and reverse transcriptase (T.P. St. John and R.W. Davis
~1979~ Cell 16 443-452). About 80 recombinant phage which
hybridize intensely to the labelled cDNA were picked from the
plates and stored in TY medium at 4 degrees C. Samples of
th0 intact phage were amplified by growth overnight on CGE5
cells, harvested by centrifugation, and subjected to
electrophoresis in a 2% agarose gel containing 0.37M
Tris-glycine pH9.5 and stained with ethidium bromide after
treatment in 0.2N NaOH for one hour and neutralization in
0.5M Tris HCl pH7.4. The migration is inversely
proportional to the log of the size of the phage DNA and
allowed selection of eight phage carrying inserted DNA of
size l000 to 2000 base pairs. Double-stranded RFI DNA was
prepared from these eight phages by the method of Moses et al
(P.B. Moses, J.D. BoeXe, ~.Horiuchi & N.D. Zinder ~1980~
Virology 104, 267). Thi~ DNA was cut with Hind IlI and the
resulting fragments analyzed on an agarose gel to confirm
that the insert was in the Hind III site and of the
anticipated size. Finally, the DNA from four of the
-70-

1~7;3883
recombinant phages (approximately 5-10~9 from each~ and DNA
from the vector CGF4 was cut with Hind IIl and the fragments,
after denaturation by boiling for 45 seconds and freezing in
dry ice/ethanol, were bound to nitrocellulose by spotting the
DNA in water onto small pieces of nitrocellulose pretreated
with 20x SSC and dried. After baking in vacuo at 75 degrees
C for 1.5 hours, the DNA bound to nitrocellulose was carried
through the hybrid selection procedure as described by Miller
et al (J.S. Miller, R.P. Ricciardi, B.E. Roberts, B.M.
Pater~on & M.B. Mathews C1980] J. Mol. Biol. 142, 455-488)
u~ing 2~g poly A-enriched calf stomach RNA for each
hybridization. The eluted RNA was then translated in a
reticulocyte lysate system labelling with 35S-methionine by
the method of Pelham and Jackson (H.R.B. Pelham & R.J.Jackson
~1976] Eur. J. Biochem. 67, 247-256) and the resulting
protein products analyzed on a 10% polycrylamide gel
containing 0.1% SDS according to Laemmli (U. Laemmli C1970]
Nature 227, 680-685). The results of the gel analysis
indicated that all four of the phage DNAs tested did
hybridize to the rennin mRNA since all four selected an RNA
species which, upon translation in a rabbit reticulocyte
lysate, yields a protein product identical to pre-prorennin
in size and immunological criteria. Two of the four, 293-207
which has an insert of about 1400 base pairs (bp) and
293-118/37 which ha~ an insert of about 1250 bp, were chosen
for further study. The DNA inserts were sequenced by the
-71-
.
. :. - .
~ ~ .

1~73~3
method of Maxam and Gilbert (A.M. Maxam and W. Gilbert ~1980]
Methods in Enzymology 68, 499-560). Fron nucleotide 205 to
1350 is the DNA sequence for the pre-prorennin A gene (see
Table 9). The nucleotide sequences 1-204 and 1351 to 1460
are attached to the pre-prorennin but can be removed if
desired and are not essential to use of the gene in
expression. Useful portions of the DNA material of Table 9
can be separated and used by known techniques.
.
-72-
.. I , , - .
: ' ~' ' ' - ,
,
.
,
-: ~
. ' '.' -" ..

lZ738~33
TABLE 9
o o o Y ~ o ~ ~ ~ 5 Z Y ~ ~ ~ 8 ~ y ~ 5 o Y ~ E w ~ ~ 5
~ ~ O ~ O ~ o O ~ 3 3
a Ye
E ~ 0 ~ ~ y ~ O O ~ 3 o o ~ Z y = y
y ~0 ~ o ~ ~ ~;
E~ 0~ ~Z ~s 0~ 3~
Y ~ Y~ ~ ~ ~o Y~ ~Yo~ ~0~ ~;~ y
o ~ z. y~ ~ YO~ ~30 oo ~3 ~o
o~ o~ o~ Y~ ~
o ~ 0 ~ y s ~ ~ 0 ~ Yo ~ E ~ U
y ~ ~ o ~ ~ ~ y ~ ~ ~ Y ~ ~ 0 30 ~ ~ Y 3
0~ y~ oO~O ~ 3 -3~ 8
0~ ~0~ Es ~, uO,
e ~ o ~o t; '~ 3 ~ ~ ~ ~ Z ~ Z ~
~ ~ ~ ~ 6 o o 0 ~ 5 ~ ~ o z
u8~ y@ YO~ ~0 ~ 0~O ~0~ ~3 O~ ~ O
O ~ O O O O ~ S Yo e Yo ~ ~ S ~ o o ~ @ ~ ~ 8 ~oi ~ ~
u ~ o ~ ~ o ' ~ 3 Yo
~ 8 ~ ~o Y ~ gZ u8o 0~ uu ~ ~3 y~ ~ 0~O ~ 3 ~ ~
o~ z ~ ~3 ~ vs IY ~ ~o ~ ~ 3 ~ E
~e i~ ~ ~o ~ 4 ~ S ~ ~ Y ~ Y ~ Y ,~ O
',
,~ .
- 73
' - - . ' - ~ ,
, -
-
: . ~ -

1~73~383
mhis Tabl~ combines information from both 293-207 and
293-118/37: recombinant phage 293-207 carries an insert
bearing the sequence shown in Table 9 from nucleotide ~1 to
at least nucleotide ~1360 except for nucleotides 848-961
which are deletea, while phage 293-118/37 carries an insert
-bearing the sequence from nucleotide ~229 to nucleotide
~1460. As revealed by the sequencing results, initiation of
rennin synthesis occurs at a methionine codon (nucleotides
205-207) and results in a pre-prorennin molecule ~ith sixteen
additional amino acids compared to purified prorennin (The
prorennin B amino acid seguence was published by B. Foltmann
et al~ Proc. Nat. Acad. Sci. USA 74 2321-2324(1977) and B.
Foltmann et al J. Biol. Chem. 254 8447-8456 (1979); the
nuc,leotide sequencing data of Table 9 is the first indication
for the existence of pre-prorennin). Together, the two
recombinant fl phages 293-207 and 293-118/37 carry the DNA
sequence for the entire pre-prorennin A molecule. The
; prorennin portion of the pre-prorennin A differs from
prorennin B at amino acid ~290 (aspartate in rennin A and
glycine in rennin B as described by Foltmann et al Csee
above]; amino acid position numbering is that of Foltmann).
An asparagine codon is shown at amino acid position ~204
while Foltmann reported an aspartate at that position;
however, this may be an amino acid sequencing error since the
amides of aspartate and glutamate are difficult to
distinguish from their acid forms, while nucleotide
sequencing can readily distingui~h the codons.
-74-
~ ~': . ' . ' ' '
,' ' ~ ' ' ' '

lZ73~8;~
The cloned rennin gene represented by phage 293-118/37
was used to investigate properties of the bovine genomic copy
or copies of the rennin gene. These experiments were done by
hy~ridizing cloned rennin DNA labelled with 32p by the
method of nick-translation (P.W.J. Rigby, M. Dieckmann, C.
Rhodes, and P. Berg Cl977] J. Mol. Biol. 113, 237-251) to
bovine DNA cut with various restriction enzymes, separatea
with an agarose gel and transferred to a nitrocellulose
membrane according to the method of Southern (E.M. Southern
10 C197s] J. ~ol. siol. 98, 503-517). The results indicate that
restriction endonuclease cleavage of the bovine DNA with
enzymes such as SacI and BglI, which do not cut the cloned
pre-prorennin cDNA sequence, nevertheless frequently yields
more than one band of DNA which will hybridize to the rennin
sequence. This suggests (a) that the genomi. copy of rennin
information contains additional DNA, presumably intervening
sequences, which contain restriction enzyme sites not found
in rennin cDNA, or (b) that more than one rennin gene exists
in the genome and some restriction enzymes cut between the
copies. This latter possibility was eliminated by
hybridizing re~triction cut bovine genomic DNA with
32P-labelled probes derived from the 5' and 3' ends of the
cloned rennin cDNA. These results, using restriction
endonucleases EcoRI and Ba~HI for example, are consistent
with a single genomic copy of rennin coding information.
:
-75-

1273883
This mean~ that A and B forms of rennin observed by B.
Foltmann et al (J. Biol. Chem. 254, 8447-8456 C1979]) are
most likely the products of two different alleles of the
rennin gene. Furthermore, the bovine genomic copy of the
rennin gene contains intervening sequences, and in that
respect the genomic copy is different from our cloned cDNA
gene which is identicai to the messenger RNA for
pre-prorennin.
6. Expression of Prorennin in Yeast
Recombinant fl phaye CGF 293-207 RFI DNA (40~ g) was cut with
Bind lII (N. E. Biolabs, 15 units~ and Bgl II (N. E. Biolabs,
14 units) for one hour at 37C in a 103J~1 reaction volume as
described previously. The restriction cut DNA was applied to
a preparative horizontal agarose gel, and the 435 ~p 293-207
piece was excised and eluted by freezing and crushing the
agarose chunk. After ethanol precipitation, the DNA was
redi6solved in water and about 1~ g was partially cut with
Hhal (N. E. Biolabs, 0.06 units) for lS minutes at 37C to
obtain the 190 bp HhaI to BgeII piece containing the pR
gtart. Thi6 DNA fragment was isolated by gel as described
previously and rendered blunt-ended by treatment with DNA
polymerase I (Boehringer Mannheim, 14 units) in a 30~ 1
reaction containing 60mM tris-HCl, pH 7.5, 8mM MgC12, lOmM
dithiothreitol, lmM ATP and 0.2 mM of

lZ73~3
each deoxynucleotide triphosphate for 30 minutes at roo~
temperature. The DNA was phenol extracted and ethanol
precipitated.
A synthetic oligonucleotide bearing an Xba I restriction
endonuclease sequence ending with ATGG, (i.e., CCATCTAGATGG)
was synthesized by the triester method (K. Itakura, et al.,
J. Biol. Chem. 250 4592 ~1975~) by Collaborative Research,
Inc. and 5 ~g was kinased with X -p-ATP using 6 units of
T4 polynucleotide kinase (P-L Biochemicals) in a 35~ 1
reaction containing Tris HCl pH 7.6, lOmM MgC12, lOmM
2-mercaptoethanol and 2 nmoles ATP. This 5'-labelled
- oligor.ucleotide (22 p-moles ends) was added to about 0.5
pmoles of the 190 bp fragment with buffer plus 500 unites of
T4 DNA ligase (N.E. Biolabs). The reaction was incubated
at 15-C for one hour then at 4C overnight, and then diluted
with four volumes of 180mM NaCl, 7mM MgC12 and 5mM Tris
HCl, pH 8. After heating at 65C for five minutes, the DNA
was trFated with 12 units of XbaI restriction endonuclease (5
unit~ additionally were added after one hour for a total of
1.5 hours of digestion). Finally, the oligonucleotide
monomers were removed from the linkered 190 bp DNA by gel
electrophoresis (7% polyacrylamide gel). The D~A fragment
was eluted from the acrylamide chunk by soaking in buffer for
24 hours. The DNA was ethanol precipitated, redissolved in
15~41 of water and incubated in a ligation reaction
containing 0.5~9 of ~GF12-fl vector opened at Xba I site
-77-
:'.' ~ - '
' .
,

~Z73~3
and the~ treated with al~aline phosphatase as described
previously. Aliquots of the ligation reaction were used to
transform competent cells of strain LG90 as described above.
The transformed cells were plated on tryptone-yeast extract
plates containing fl sensitive cells (JM101). Several phage
plaques were picked and small cultures of each were grown to
provide a small amount of RFl DNA. Restriction endonuclease
digestion (XbaI and HaeIII) and agarose gel electrophoresis
revealed that some phage clones carried the desired 190 bp
fragment in the desired orientation (5'-end of prorennin gene
adjacent to the single EcoRI site of CGF12). One such
isolate was named CG~21.
About 10 ~ g of the CGF21 DNA was cut with PstI (N E~
Biolabs, 7 units) for 45 minutes at 37C in a 40ml reaction
as previously described. The Pst I cut DNA was then with
EcoRI (N.E. Biolabs, 10 units) for 45 minutes at 37 DC. The
100 ~p PstI/EcoRI fragment was isolated by acrylamide gel.
The plasmid pBR322 (~8 ~ ) was cut with EcoRI (N.E. Biolabs,
7.5 units) and HindIII ~N.E. 8iolabs, 7.5 units) for one hour
at 37 C in a 30 ~ 1 reaction volume. The resulting
HindIII/EcoRI fragment (4.3Kb) was purified by agarose gel.
CGF293-118/37 DNA (10 ~ g) was cut with PstI (N.E. Biolabs, 8
units) and HindIII (N.E. Biolabs, 10 units) for one hour at
37-C in a 30 ~1 reaction volume. m e l.lkb PstI/HindIII DNA
fragment was purified by agarose gel. The three DNA
fragments were joined in a tri-molecular ligation reaction to
-78-
.
- . ., ' - . : .' ' . .
- ' . ' ~ '

1;~73~3
yield pCGE68. The tri-molecular ligation (reaction v~olume
27~1) contained approxi~ately equal molar proportions of the
three frag~ents totaling 1.5~4g DNA. The ligation reaction
was carried out with 400 units T4 DNA ligase (N.E. Biolabs)
at 12 DC for 8 hours. Aliquots of the ligation reaction were
used to transform competent cells of strain LE392 as
described. Analysis of the plasmid DNA by restriction enzyme
digestion (PstI, Xbal, Bgell and ~I) and ~garose gels
revealed that some isolates carried the desired plasmid
pC OE68. This plasmid contains the DNA encoding Met-prorer~in.
~he pCGE68 DNA (lO~ g) was cut with XbaI (N.E. Biolabs,
10 units for 2 hours at 37C. After precipitation with
ethanol, the DNA was rendered blunt ended by treatment with
Sl nuclease (30 units) for 30 minutes at 37C. After phenol
extraction and ethanol precipitation the DNA was incubated
with 5'-phosphorylated SalI linker (Collaborative Research,
2.5 ~ g). The linker had been kinased with ~-22P-ATP using
2.5 units of T4 polynucleotide kinase (P-L Biochemicals) in
a 10J4l reaction containing lOmM Trifi-HCl, pH 7.6, lOmM Mg
C12 lOmM 2-mercaptoethanol and 0.12 nmoles ATP. The linker
was ligated to the blunt-ended pCGE68 DNA in a 25~1 reaction
for 8 hours at 14-C. The resulting ligated DNA containing a
SalI linker was used to transform competent cells of strain
BNN45. Restriction enzyme (SalI) and agarose gels were used
to identify the desired plasmid, pCGE91.
-79-
- ~

~;~73~383
The construction of prorennin in yeast was now begun.
The first yeast vector of interest, pCGS128, was made from a
ligation of three pieces. First, pCGE91 wa~ cut with Salr
(N.E. Biolabs, 10 unit~) for 3 hours at 37C. This DNA
fragment was then rendered blunt-enaed by treatment with DNA
polymerase I (soehrin9er/Mannheim~ 10 units) in a 50~ 1
reaction containing 10 mM Tris-HCl, pH7.5, 8mM MgC12, lOmM
dithiothreitol, and 0.2mM of each deoxynucleotide
triphosphate for one hour at room temperature. The blunt
ended DNA was then ethanol precipitated, redissolved and cut
with HindIII (N.E. Biolabs, 7.5 units) for 1 hour at 37C.
The 1200 bp blunt-ended SalI/HindIII DNA fragment was
purified by àgarose gel electrophoresis. The next DNA
fragment containing the necessary components of a shuttle
vector was purified from cCGS40. This latter vector was cut
.
with EcoRI and HindIII and the resulting 7000 bp fragment
was purified by agarose gel electrophoreies. The third DNA
.. ... .
fragment containing the PGALpromoter came from pBM125
(courtesy of R. Davis, Stanford University) which was cut
with BamHl, blunted with DNA polymerase I plus all four
deoxyllucleotide triphosphates, then cut with EcoRI to yield
a 820 bp piece designated PGALl25. m e nucleotide
sequences depicting the promoter lengths are shown in Table
1. The three pieces of DNA (1200bp from pCGE9l, SalI
blunt-ended/HindIII, 7000 bp from pCGS 40 EcoRI/HinaIII, and
820 bp from PGAL125) were ligated together using equimolar
-80-
' ;'' ' ' ~ ' ' ` ' -
.

lz73883
amounts of the fragments in a 25J~1 reaction containing ~4
DNA ligase (Collaborative Research, 2 blunt-ended units) and
appropriate buffers and ATP and incubated for 18 hours at
14-C.
The ligated DNA was used to transform competent cells of
strain CGE129. Analysis of the plasmid DNA by restriction
enzyme digestion and agarose gel revealed isolates which
carried the desired plasmid pCGS128. DNA of pCGS128 was used
to transform yeast strain CGY150. The transformed
sp~leropla~ts were selected. Western protein blot analyses
revealed that the yeast strain carried prorennin (~0.02~).
In order to increase the expression of prorennin an
additional construction was carried. The pCGS128 DNA was cut
with HindIII. A fragment (pRB58) from the 3' end of the SUC
2 gene was cut with HindlII, made blunt-ended with E. coli
DNA polymerase I and then SalI linkers were ligated on. The
resulting fragment was cut with SalI and BamHl to produce a
gel purified 1 kb DNA fragment which was ligated into p CGS40
cut with BamHl and SalI.
The resulting vector, pCGS108, was cut at Hpal and SalI,
made blunt with E. coli DNA polymerase I and gel purified.
HindlII linker (Collaborative Research, 10 nucleotides long)
were ligated to the DNA fragment which was then cut with
- HindIlI and gel purified to produce a 650 bp fragment which
was ligated into the ~indlll site of pCGS128 to produce
; pCGS108.
~ -81-
1 ' .
- ~
.' ''
'

7~ 3
A partial EcoRI and SalI cut was made of the pCGS168
vector to isolate a 2.6kb DNA fragment containing PGAL125
and prorennin. A partial EcoR1 cut was made from FJDB219 to
produce a gel purified 2.3 kb fragment containing the LEU2
gene on a 2~ DNA fragment. These two DNA fragments were
ligated together with a EcoRI/SalI digest fo Ylp5 (containing
selection for URA3 to yield pCGS241 and ~CGS242 (Table 10).
The difference in structure is due to the two orientations of
the 2.3 kb fragment. Both vectors were separately used to
transform CGY150. Analysis of the plasmid DNA by restriction
enzyme digestion and agarose gel revealed the desired plasmid
with the level of prorennin expression via western analysis
was increased to 0.2~ of the soluble protein. The protein
demonstrated milk clottin~ activity after conversion to
rennin.
Strain CGY461 bearing plasmid pCGS242 is on deposit with
the American Type Culture Collection (ATCC~, Accession Number
20662, deposited February, 1983.
-82-
.
,

~7~ 33
TABLE 10
LEU2 2~
~ Eco RI
Eco RI / ~ GALl promoter
~ \ (12~)
Ampr / ~ ~lunt joint
. . Prorennin A
: pCGS242
\
origln \ ~ Hind III
~ / SUC2 (3' end)
" \ \/
URA3 ~ I
.'
-83-
,
;._~ ,,~ . . .
' ~ - '
'
.
. .
:`
~: '' . `

EXAMPLE 4
. . . _
Production of Pre-prorennin
Steps 1 through 5 of Example 3 were repeated for this
experiment.
6. Expression of Pre-prorennin in Yeast
Recombinant fl phage CGF 293/207 RFI DNA (20~u g)
was cut with AvaII (N.E. Biolabs, 5 units) in a 100~ 1
reaction. The 256 bp AvaII fragment was purified by gel
electrophoresis and made blunt-ended with E. coli DNA
polymerase 1 Klenow fragment. After phenol extraction and
ethanol precipitation, the DNA was ligated with HindIII
linker (Collaborative Research, CAAGCTT G) then cut with
HindIII (N.E. Biolabs, 15 units) and BglII (N.E. Biolabs,
3.6 units). A 245 bp fragment was purified by gel electro-
phoresis containing part of the preprorennin gene. Plasmid
pCGS28 DNA (British Patent No. 2,091,271 issued August 30,
1984 to B. Alford, et al.) was cut with BglII (N.E. Biolabs,
5 units( and SalI (N.E. Biolabs, 10 units) and a 1000 pb DNA
fragment containing the rest of the preprorennin gene was
purified by gel. These two DNA fragments were ligated
together with pBR322 cut with HindIII (N.E. Biolabs, 12
units) and SalI (N.E. Biolabs, 8 units). This vector was
used to transform competent E.coli cells and
-84-

~738~;~
the resulting restriction enzyme analysis of plasmid DNA from
several E. coli clones revealed the desired plasmid pCGE63 in
E. coli strain CGE130.
The preprorennin gene was used to construct PCGS148 which
i8 PGAL126 preprorennin. Plasmid PCGE63DNA was cut with
HindIII and SalI to yield a 1200 bp fragment containing
preprorennin DNA. A EcoRI/HindII I double digest was carried
out on pRB118 to obtain a 850 bp fragment containing
P8UC2. These fragments were ligated in a tri-molecular
reaction as described with an EcoRI/SaII fragment of pCGS40
which imports the characteristics of a shuttle vector. The
mixture was used to transform competent C OE129 E. coli
cells. Clones of E. coli carrying the desired plasmid PCGS64
were identified by restriction digestion of plasmid DNA from
several transformants.
A BglII/SalI fragment ~9 kb) of pCGS64 was purified by
gel electrophoresis and contained part of the preprorennin
gene, as well as the pCGS40 EcoRI/SalI fragment. A
BglII/Xho-I 3600 bp fragment of pCGE74 containing the rest of
20 preprorennin fused at the SmaI site in preprorennin gene
moist of the E. coli 3-galactosidase gene was ligated to the
piece from pCGS64. Transformation was carried out and
restriction analyses showed the presence of the desired yeast
plasmid pCGS81.
-85-
.
; ' ' ' .
.
- , .. .

~.27;~83
The Psuc2 was removed from pCGS81 by restriction first
with HindIII followed by filling in with E. coli DNA
_
polymerase I Klenow fragment. The opened plasmid was then
restricted with EcoRI and the large fragment minus P8UC2
was gel purified. The PGAL126 was obtained by restriction
of pBM126 (courtesy R. Davis, Stanford, University). The
plasmid psMl26 was cut with BamHl and filled in with E.coli
DNA polymerase I Klenow fragment and then cut with EcoRI to
yield the desired 750 bp PGAL126. These two fragments were
ligated together to get pCGS148, which contains PGAL126
preprorennin 'Z (where 'Z represents a portion of
B-galactosidase gene).
A 1000 bp piece of DNA was obtained by digesting pCGS148
with EcoRI and ~ II. In addition, the BglII/SalI 1800 bp
fragment of pCGS168 was gel purified. These two fragments
were ligated with the 8~b Eco~I/SalI fragment of pCGS 40 in
excess. Transformation of competent E. coli CGE129 was
carried out and restriction analysis revealed clones carrying
the desired plasmid pCGS240 (Table ll). Plasmid DNA prepared
20 from E. coli carrying pCGS240 was used to transform yeast
strain CGY150. Yeast strain CGY457 re~ulted from that
transformation and carries plasmid pCGS240. The level of
expression of protein from the GALl promoter as demonstrated
by western hybridization with rennin antibody was ~0.2~ of
the soluble protein.
. , .
-86-
: , '-
~ ~ ,
. , . ~ .~ ' : '

~f~73~
Strain CGY457 bearing plasmid pCGS240 is on deposit with
the American Type Culture Collection (ATCC), Accession Number
20661, deposited February, 1983.
-87-
-
' ~ :

~.~73~8;~
TAsLE 11
GALl
promoter
(126)
Eco RI ~ Blunt joint
>~ ~
~\
Ampr / X
\P.reprorennin
_ ~ d III
pCGS240
UC2 (3' end)
\ ~ Sal I
E. coli\
origin
URA3
origin
.
-88-
..:
,
..
.
.
:
.

Representative Drawing

Sorry, the representative drawing for patent document number 1273883 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: CPC removed 2001-05-18
Inactive: CPC assigned 2001-05-18
Inactive: CPC removed 2001-05-18
Inactive: CPC assigned 2001-05-18
Inactive: First IPC assigned 2000-01-13
Inactive: IPC assigned 2000-01-13
Inactive: IPC removed 2000-01-13
Inactive: IPC removed 2000-01-13
Inactive: IPC assigned 2000-01-13
Inactive: Adhoc Request Documented 1994-09-11
Time Limit for Reversal Expired 1994-03-12
Letter Sent 1993-09-13
Grant by Issuance 1990-09-11

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
COLLABORATIVE RESEARCH INC.
COLLABORATIVE RESEARCH INC.
Past Owners on Record
ALISON TAUNTON-RIGBY
CHRISTOPHER G. GOFF
DAVID BOTSTEIN
DONALD T. MOIR
GERALD R.ALISON FINK
JEN-I MAO
ROBERT G. KNOWLTON
RONALD W. DAVIS
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1993-10-08 1 5
Cover Page 1993-10-08 1 17
Claims 1993-10-08 3 54
Drawings 1993-10-08 1 5
Descriptions 1993-10-08 89 2,365
Fees 1992-08-12 1 50